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ABSTRACT 
 
High Resolution Optical Imaging Techniques for Rapid Assessment of Breast Cancer 
by 
Jessica Dobbs 
Breast cancer is the most prevalent and deadly cancer among women worldwide. The 
current standard for breast lesion diagnosis is histologic assessment with hematoxylin and eosin 
(H&E) staining. Histology has high diagnostic accuracy, but requires extensive time and 
resources to perform. The objective of this work was to improve diagnosis of early breast cancers 
by developing approaches to rapidly image and characterize neoplastic tissue and the tumor 
microenvironment in high resolution optical images. 
Confocal fluorescence microscopy can image optical sections of tissue without the need 
for extensive tissue processing. Three studies were performed to evaluate if confocal microscopy 
images contain sufficient information to identify neoplasia in breast tissue. In a 31 patient study, 
five pathologists identified neoplasia with high accuracy in confocal and histologic images. In 
another study, an expert pathologist estimated tumor cellularity in core biopsies with moderate 
agreement between confocal and histologic images. In a third study, an expert pathologist 
assigned diagnoses and grades to neoplastic tissue in confocal and histologic images. Limitations 
of these studies include recruitment of patients at a single center and data assessment by a single 
reader in two of three studies.  
Visual assessment for cancer diagnosis is limited by the potential for inter- and intra-
observer error. Using a computerized algorithm to segment and quantify architectural features of 
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breast ducts and nuclei, a decision-tree model was developed that classified confocal images of 
breast tissue sites as neoplastic or non-neoplastic with an overall accuracy of 90%. Another 
computerized algorithm was developed to segment adipocytes in confocal images and results 
showed significant differences in phenotypic properties of adipocytes adjacent to neoplastic and 
non-neoplastic tissue.  
High resolution microendoscopy (HRME) can be used to rapidly acquire images at a 
lower cost than confocal microscopy. In a study evaluating HRME and two approaches to 
improve image contrast, results demonstrated that HRME with structured illumination yields 
images with high contrast relative to HRME with standard illumination.   
The unique contribution of these results is the characterization of qualitative and 
quantitative criteria to evaluate breast tissue and classify neoplasia in optical images, although 
recognition of invasive lobular carcinoma was limited. The criteria developed in this research 
may be applied to further development of techniques for objective classification and diagnosis of 
breast cancer in optical images.  
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1 CHAPTER 1: Introduction 
1.1  Objective and Specific Aims 
The objective of this work was to improve the diagnosis of early breast cancers through 
the development of approaches to analyze high resolution optical images of breast tissue and 
quantitative criteria to characterize breast lesions and the tumor microenvironment. The 
following specific aims were designed to achieve this objective: 
Specific Aim One:  Evaluate the feasibility of identification and characterization of 
normal, benign, and malignant breast features in images acquired 
with confocal fluorescence microscopy.  
Specific Aim Two:  Characterize morphological features of stromal adipocytes in the 
breast tumor microenvironment to identify differences in adipocyte 
phenotype in normal tissue and adjacent to malignant lesions. 
Specific Aim Three:  Explore structured illumination and Lugol’s Iodine as potential 
methods to reject background light in images acquired with high 
resolution microendoscopy. 
1.2 Chapter Summaries 
This dissertation describes the studies performed to accomplish these specific aims in the 
following chapters: 
Chapter 1 lists the specific aims of this research and provides an overview of the 
research to be discussed.  
Chapter 2 provides background information on the motivation and significance of this 
work, a brief overview of breast anatomy and histology, and a discussion on the role of breast 
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stroma in tumor progression and invasion. Current clinical breast imaging modalities and optical 
imaging techniques in development for breast imaging are reviewed.  
Chapter 3 describes the development of a library breast tissue images acquired with 
confocal fluorescence microscopy and criteria for visual assessment and interpretation of benign 
non-neoplastic features, benign proliferative features, and neoplasia. The library and assessment 
criteria were used to perform a validation study in which five readers visually assessed confocal 
and histologic images based on the presence of neoplasia. Chapter 3 was published previously in 
Journal of Biomedical Optics [1]. 
Chapter 4 describes the results of a study in which tumor cellularity was estimated in 
grayscale confocal, pseudo-colored confocal, and histologic images of core needle biopsy 
specimens from patients diagnosed with inflammatory breast carcinoma. Chapter 4 was 
published previously in Breast Cancer Research and Treatment [2]. 
Chapter 5 describes the results of a study in which a diagnosis and tumor grade  were 
assigned to histologic images of neoplastic breast tissue specimens based standard histologic 
criteria and to confocal images using the modified criteria described in Chapter 3 [1].  
Chapter 6 describes the development of computerized algorithms to segment and 
analyze quantitative ductal and nuclear features in confocal images of breast tissue. These 
algorithms were used to create a decision tree model to classify neoplastic and non-neoplastic 
breast tissue in confocal images. Chapter 6 was published previously in Breast Cancer Research 
[3]. 
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Chapter 7 describes the development of a computerized algorithm to segment and 
analyze parameters of adipocytes in confocal images acquired from the microenvironment of 
neoplastic lesions and in non-neoplastic stroma.  
Chapter 8 describes the evaluation of two methods to potentially improve contrast in 
images acquired with high resolution microendoscopy, including structured illumination and 
topical application of Lugol’s Iodine.  
Chapter 9 provides a summary of the research presented in this dissertation.  
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2 CHAPTER 2: Background 
2.1  Motivation and Significance 
Breast cancer is the most common form of cancer among women worldwide. It was 
estimated that in the year 2012 there were approximately 230,000 new cases of breast cancer and 
40,000 deaths due to breast cancer among women in the United States [4, 5]. There were an 
estimated 1.4 million new cases and 460,000 deaths worldwide in women due to breast cancer 
over the same period [6]. The incidence of invasive breast carcinoma varies in different 
geographical regions, with the highest incidence rates seen in western and northern Europe, 
Australia and New Zealand, and North America. [6]. The two clinical factors thought to have the 
greatest influence on breast cancer risk are gender and age; breast cancer incidence increases 
with age and the incidence rate for breast cancer is approximately 100 times higher in women 
than in men [5, 7]. Increased breast cancer risk is associated with many other clinical factors 
including family history of breast cancer, a mutation in the BRCA 1 or 2 genes, long menstrual 
history, use of hormone replacement therapy, prior history of breast cancer, and lack of access to 
screening services [6]. Some well-documented behavioral risk factors for breast cancer in the 
United States include being overweight or obese, a sedentary lifestyle, lack of physical activity, 
moderate or high consumption of alcohol, and tobacco use [8, 9]. 
Breast cancer is classified by stage, which is based on assessment of tumor size, lymph 
node involvement, and metastasis, and impacts the course of treatment. Women with early stage 
disease (Stage I, IIA, or IIB disease) undergo surgical resection of the lesion through 
lumpectomy or mastectomy, post-surgical radiation therapy, and possible chemotherapy based 
on the number of axillary lymph nodes involved. Treatment of regional and distant disease 
(Stage III and IV) involves total mastectomy followed by radiation therapy and / or targeted 
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chemotherapy. Chemotherapy regimens can be administered pre- or post-surgical resection 
depending on the extent of disease. Pre-surgical chemotherapy may be used to decrease tumor 
bulk to increase the possibility of total surgical resection. Chemotherapy regimens generally 
consist of a combination of targeted agents, which are selected according to tumor metabolism 
and stage of disease [10].  
Five-year survival rates for invasive breast carcinoma among all women in the United 
States are highest (99%) when the disease is localized at the time of diagnosis [11, 12]. When 
breast cancer is at the regional stage, five-year survival is 85% and when the primary tumor has 
metastasized to a distant location, five year survival is 25% [12]. Five-year survival rates in the 
United States differ by race: African American women are observed to have a much lower rate of 
survival (79%) than non-Hispanic white women (90%), Asian American women (90.3%), 
American Indian women (85.6%), and Hispanic women (83.8%) [5, 12].  The lower survival rate 
for African American women is influenced by lower access to health care, high quality cancer 
screening and treatment facilities, which results in later stage at diagnosis [4, 5, 13]. There is a 
critical need for improved early diagnostic techniques, which are affordable enough to enable 
access to all racial and socioeconomic groups.  
2.2 Breast Anatomy and Histology 
2.2.1 Normal Breast Anatomy and Histology 
Female breasts are organized into several lobes, which are innervated by a network of 
ducts radiating from the base of the nipple. Although several texts describe breasts as having 
between 15-20 lobes and milk ducts [14, 15], more recent studies have identified breasts with 
averages of 5-9 milk ducts [16-18]. As they lead away from the nipple, large milk ducts branch 
into smaller vessels which extend to the lobules. The ductal epithelium is made of columnar and 
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cuboidal cells, and the layer between the epithelium and basal lamina is made up of 
myoepithelial cells. The portions of ducts extending into lobules and the lobular units are called 
terminal ductal lobular units (TDLUs). Lobules are clusters of many alveolar glands, which 
secrete fluid during lactation. During a resting (or non-lactating state), lobular glands are 
surrounded by a layer of cuboidal cells and reinforced by myoepithelial cells.  
 
Figure 2-1: Diagram of the ductal and lobular architecture within the breast (Breast care: a clinical guidebook for 
women’s primary health care providers, Development and growth of the breast, 1999, p. 34, Figure 3.7, WH Hindle, 
©Springer-Verlag New York 1999. Used with permission of Springer [19]).  
 
Significant changes to the molecular structure and composition of the breast occur during 
puberty, pregnancy, lactation, and menopause. Prior to puberty, the breasts are composed of 
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collagenous and adipose tissue, with little glandular tissue [15]. During puberty, an increase in 
the hormones estrogen and progesterone cause the breast to grow to its mature size through 
ductal growth and lobular differentiation and growth [15]. The mature, non-lactating female 
breast is composed of approximately equal amounts of glandular and adipose tissue. During 
pregnancy and lactation, the amount of glandular tissue increases to approximately twice that of 
adipose tissue [16, 20, 21]. Alveolar glands within the lobules secrete fluid and lobular epithelial 
cells show abundant vacuoles. When a woman is breastfeeding, milk is transported from the 
lobules, through the network of ducts, and to the nipple [16]. After lactation ceases milk is no 
longer produced, and the number and size of lobules decreases [15]. During menopause ductal 
and lobular epithelia undergo atrophy in response to a decrease in systemic estrogen and 
progesterone levels. Thus the quantity of glandular tissue decreases and the breast is primarily 
composed of adipose tissue and collagenous stroma [15].  
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Figure 2-2: Representative high magnification histologic images of benign and malignant breast tissues stained with 
hematoxylin and eosin. A: Usual ductal hyperplasia. B: Atypical ductal hyperplasia. C: Comedo DCIS. D: Solid DCIS. E: 
Invasive ductal carcinoma of the breast. F: Invasive lobular carcinoma of the breast. Scale bars are 100 µm.  
2.2.2 Benign Breast Conditions 
There are a number of benign breast conditions that can occur in a normal female breast. 
Inflammation, which is a local increase in lymphocytes, is an immune response. Fibrosis is a 
localized increase in connective tissue that occurs during the formation of scar tissue in response 
to injury or infection. Lobules in aging breast tissue may undergo sclerosing adenosis, which 
causes the lobular alveoli to unfold and display disorganized histology. Ducts can also display 
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hyperplasia without atypia (usual ductal hyperplasia, Figure 2-2A), which is an increase in ductal 
epithelial cells that do not show abnormal histology such as increased mitotic events, 
pleomorphism, or increased nuclear size [15].    
 
Figure 2-3: Revised Wellings and Jensen model of human breast cancer evolution. Reprinted from Clinical Cancer 
Research, 2008, 14/2, 370-378, Allred DC et al., Ductal carcinoma in situ and the emergence of diversity during breast 
cancer evolution, with permission from AACR [22]. 
 
2.2.3 Breast Carcinogenesis 
The transition from normal to malignant breast tissue is a complex process. Originally, 
this transition was thought to be a continuum: normal TDLUs became hyperplastic enlarged 
lobular units (HELUs) after undergoing increased growth, HELUs progressed to atypical ductal 
hyperplasia (ADH) through a loss of adhesion and polarity and progression from ADH to ductal 
carcinoma in situ (DCIS), which progressed to invasive breast cancer (IBC) as carcinoma cells 
invaded the surrounding stroma [23].  This model was revised by Allred et al. [22] to reflect  a 
more gradual, less obligatory transition from ADH to DCIS (Figure 2-3). In this revised model, 
some ADH foci progress to low grade (well-differentiated) DCIS, which may undergo many 
genetic and epigenetic changes towards high grade (poorly-differentiated) DCIS [22].  
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2.2.4 Pre-invasive breast cancer  
Atypical ductal hyperplasia (ADH) is generally described as having some features of 
usual ductal hyperplasia and some features of ductal carcinoma in situ (DCIS). ADH is 
histologically distinguished from usual hyperplasia by increased mitotic activity and 
pleomorphism, and decreased cellular adhesion and polarity (Figure 2-2B) [15, 24]. There are 
various qualitative methods of distinction between ADH and DCIS which are somewhat 
arbitrary, including number of duct cross-sections affected and cross-sectional diameter [15].  
DCIS appears to originate in the terminal duct-lobular unit (TDLU) [25], with exceptions 
in cases of carcinoma in major central ducts and carcinoma of the nipple [15]. DCIS is defined as 
a pre-invasive malignancy because it is confined within involved ducts and lobules. There are 
five common subtypes of DCIS with differences in architecture and malignant potential, 
including comedo, cribriform, papillary, micropapillary, and solid DCIS. Comedo DCIS is 
generally characterized as a solid proliferation of large carcinoma cells, which tend to be poorly-
differentiated and pleomorphic (Figure 2-2C) [26]. Comedo DCIS is a histology that is associated 
with poor prognosis, generally described as having high nuclear grade, aneuploidy, high 
proliferation rate, over-expression  of HER2, and aggressive behavior [27]. Some classifications 
of DCIS simply distinguish between comedo and “non-comedo” DCIS subtypes, because non-
comedo DCIS subtypes tend to have the opposite characteristics, such as low nuclear grade, 
relatively lower rate of proliferation, and less aggressive behavior [27]. Cribriform DCIS is 
characterized by the arrangement of ductal epithelial cells in back-to-back orientations to form 
micro-lumens (Figure 2-2D, right). The papillary and micropapillary DCIS subtypes are 
distinguished by folds of epithelial cells projecting into the ductal lumen; micropapillary folds 
are smaller than those in the papillary subtype. Solid DCIS features ductal lumens entirely filled 
by malignant cells, with no micropapillary structure or micro-lumens (Figure 2-2D, left) [15].  
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The management of DCIS is controversial, with treatments ranging from local 
lumpectomy to mastectomy followed by radiation therapy [27]. A recent observational study 
following over 100,000 women diagnosed with DCIS demonstrated that, contrary to the current 
clinical paradigm [28, 29], DCIS follows a similar clinical course to small, invasive breast 
cancers and some cases have the potential for distant metastasis. This study showed that the risk 
of death following a diagnosis of DCIS is higher for black women and women younger than 35 
years. However, a major finding of this study is that radiation therapy following lumpectomy for 
women with diagnosed DCIS did not lead to a significant improvement in 10-year survival rate 
relative to lumpectomy without radiation therapy [30]. 
2.2.5 Invasive breast cancer  
There are several types of breast carcinoma, commonly classified to include invasive 
ductal carcinoma, invasive lobular carcinoma, tubular carcinoma, cribriform carcinoma, 
mucinous carcinoma, papillary carcinoma, micropapillary carcinoma, medullary carcinoma, 
carcinoma with metaplasia, and inflammatory breast carcinoma. The most common form of 
invasive breast disease is invasive ductal carcinoma (IDC, Figure 2-2E), which accounts for 
approximately 80% of breast carcinomas [31]. IDC tumors are generally dense, solid tumors, 
which often metastasize to lymph nodes in the axilla and have a poor prognosis.  
The second most common breast malignancy is invasive lobular carcinoma (ILC), which 
accounts for 3-14% of breast carcinoma cases, depending on diagnostic criteria used [32-35]. 
ILC tumors are generally characterized by single file lines of uniform cells invading into stromal 
tissue (Figure 2-2F). This growth and invasion pattern is a result of low E-cadherin expression, 
which results in low cellular adhesion and motility [15, 24]. Medullary, tubular, and mucinous 
(colloid) account for 3-6% [36, 37], 1-2% [31], 1-2% [38, 39], respectively. Inflammatory breast 
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carcinoma (IBC) accounts for approximately 1% [40] of cases and is a very aggressive form of 
breast cancer, which causes edema and enlargement of the breast. IBC is characterized by young 
age at diagnosis, rapid onset and progression, and poor survival rates [41].  All other types of 
breast carcinoma account for the remaining 2% of cases [24].  
2.3 The role of breast stroma in cancer progression and invasion 
It has recently been suggested that breast stromal tissue plays a dynamic and influential 
role in breast tumor development and progression [42-45]. Collagen and adipocytes in particular 
are currently being investigated for their role in breast disease [46-51]. 
Epithelial and stromal cell proliferation is considered to be a major contributor to increased 
breast cancer risk [52]. The complex transition from normal to malignant breast tissue is thought 
to occur primarily in ductal and lobular epithelial tissue [22, 23]. It is well known that high 
mammographic breast density is associated with a 4-to-6-fold increase in breast cancer risk; 
however the molecular explanation for this association has not been fully elucidated. It was 
recently reported that high mammographic density is associated with high collagen density [52], 
which has been shown to directly promote proliferation of mammary epithelial cells in vitro and 
in murine models [47].  
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Figure 2-4: Histology of the invading front and the center of a human breast carcinoma. A: Adipocytes at the interface of 
the invading front show decreased size relative to normal adipocytes located at a short distance. B: At the center of the 
same tumor, there is an accumulation of fibroblasts and cancer-associated fibroblasts; adipocytes are not present. Scale 
bar is 100 µm.  
 
Another stromal component that plays a dynamic role in tumor behavior is adipose tissue. 
Although adipocytes are the most common cell type in mammary tissue, they are rarely present 
in the center of tumors, where there are an increased number of fibroblasts and epithelial cells 
relative to normal breast tissue. Tan et al. have found that adipocytes near the invasive front of 
breast tumors tend to be smaller in size than those located a distance from the tumor (Figure 
2-4)[49]. Another study showed that adipocytes co-cultured with breast cancer cells develop a 
fibroblast-like phenotype in which the lipid vesicles greatly decreased in size and the cells took 
on a spindle-shaped appearance [50]. One theory for this dramatic change in adipocyte 
phenotype is that, as a result of crosstalk between adipocytes and breast cancer cells, adipocytes 
undergo de-differentiation [49]. Co-culturing adipocytes and cancer cells (Figure 2-4) has shown 
evidence of this crosstalk at a molecular level, including a decrease in adipocyte markers and an 
overexpression of matrix metalloproteinase-11 (MMP-11) – an ECM-remodeling proteinase 
associated with tumor invasion and interleukin-6 (IL-6) – a cytokine associated with 
inflammation [50]. 
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Adipocytes have been shown to influence their surroundings to promote tumor growth 
and invasion [49, 50, 53]. Continued study of mammary collagen and adipocytes is needed to 
investigate the role of interaction of these components with pre-malignant lesions and to 
determine the association between phenotype and clinical outcome. Research to develop high 
resolution molecular imaging techniques to visualize these stromal components is in the early 
stages. 
2.4 Current methods for breast cancer screening and diagnosis 
Common methods for detection of breast carcinoma include self-breast exams, clinical 
breast exams, mammography, ultrasound, and magnetic resonance imaging (MRI). These clinical 
imaging techniques are commonly used to indicate the presence of suspicious lesions, but are 
limited by a number of factors including low sensitivity and specificity, and a dependence on 
age, breast density, and menopausal status [54-59].  
Clinical breast examination (CBE) of the breast is based on visual inspection and 
palpation of the breast and lymphatic areas according to standard guidelines [56]. CBE is 
performed by a physician either during a routine physical examination or following identification 
of a mass during breast self-examination. Based on findings of CBE, including appearance and 
texture of the nipple and nodularity, and size and shape of the mass, physicians record the 
findings of the CBE as either normal or abnormal - suspected benign finding or suspicious of 
malignancy. If findings are abnormal, a follow-up examination is recommended [56, 58]. Data 
from several studies on the accuracy of CBE have demonstrated that CBE identifies some breast 
cancers missed by mammography [57, 60]. Sensitivity and specificity of breast cancer diagnosis 
by CBE has been estimated by pooling results from several studies; values range from 17.9-
58.8% and 92-98.8%, respectively [55, 57, 61, 62]. 
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Mammography is used as both a screening and diagnostics technique for breast cancer in 
women. The introduction of mammography screening programs resulted in a significant decrease 
in breast cancer mortality in the United States and other countries [63-65]. During 
mammography procedures, X-ray images are generally obtained from 2 conventional views of 
the breast: cranio-caudal (X-ray from the head to the feet) and medio-lateral oblique (from the 
medial to the lateral side of the body, at an angle). The X-ray images are reviewed by 
radiologists, who assess the findings using the American College of Radiology Breast Imaging 
Reporting and Data System (BI-RADS) five point scale: 1 = negative, 2 = benign finding, 3 = 
probably benign finding, suggest a short follow up time, 4 = suspicious of abnormality, biopsy 
should be considered, and 5 = highly suggestive of malignancy [66]. Sensitivity and specificity 
values for mammography have been reported as ranges from 33-98.5% and 75-98.8%, 
respectively [59, 61, 62, 67-70]. Several studies have demonstrated that sensitivity of 
mammography is dependent on patient age and breast density: sensitivity is much lower for 
patients younger than 45-50 years, and in women with high breast density [67-69, 71]. Deceased 
mammographic sensitivity was also observed in patients with increased tumor size and a family 
history of breast cancer [69]. In addition, a recent study found that mammography is associated 
with an increased breast cancer risk among carriers of BRCA 1/2 mutations who are younger 
than 30 years [72]. 
Ultrasound (US) is another imaging technique used to assess suspicious breast lesions. 
US imaging is performed by a radiologist who evaluates the mass according to criteria describing 
lesion shape, margin features, and acoustic properties [73]. Like mammography findings from 
US scans are reported using BI-RADS categories [66]. Ultrasound sensitivity and specificity has 
been reported as values ranging from 40-98.4% and 34-96.8%, respectively [61, 62, 68, 70, 73]. 
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Similar to mammography, US sensitivity is dependent on patient age and breast density – lower 
sensitivity is associated with patient age younger than 50 and high breast density [71]. Another 
limitation of US is the tendency for overestimation of tumor size [61].  
Magnetic Resonance Imaging (MRI) for breast lesion assessment is performed using a 
standard MRI system with a bilateral breast coil. MR images are assessed using a similar pattern 
to BI-RADS classification, through integration of morphology and enhancement kinetics [74]. 
Reported ranges of MRI sensitivity and specificity are 79.5-94.4% and 26-97.2% [61, 70, 75]. 
Like US, MRI is limited by a tendency to overestimate tumor size [61]. MRI is an expensive 
procedure, with the average cost for a bilateral scan at approximately $1,000; by comparison, the 
average cost for a bilateral mammogram is approximately $50 [76].  
Although breast cancer is often detected with low resolution imaging techniques, the gold 
standard for breast cancer diagnosis is histologic assessment, an extensive and time-consuming 
process that requires core needle biopsy or surgical tissue excision and rigorous tissue 
preparation. Immunohistochemistry (IHC) is often performed on histologic slides to characterize 
expression of relevant biomarkers, such as estrogen and progesterone receptors, HER-2/neu, and 
markers of proliferation, including p53 and Ki-67 [10, 77]. Highly trained pathologists evaluate 
fixed and stained tissue samples for presence and type of malignant breast tissue based on 
standardized histologic criteria [15, 78-80]. Malignant breast tumors are graded and categorized 
to reflect their expected pattern of progression. Bloom and Richardson developed one of the 
most widely used grading systems for breast tumors, which used only qualitative criteria to 
evaluate breast lesions [78]. Elston and Ellis published the Nottigham modification incorporating 
semi-quantitative criteria into the Bloom and Richardson grading system [80].  Extensive 
research to evaluate the rate of inter- and intra-observer discordance using these grading systems 
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and while some studies have shown that inter-observer agreement is high in the majority of cases 
[81], other studies have shown that subjective criteria can lead to inter-observer variation for 
margin assessment and poor reproducibility in evaluation of borderline and in situ lesions [82-
87].  
2.5  Optical imaging for breast tissue characterization 
Optical imaging has the potential to address the limitations of conventional breast cancer 
detection and diagnosis techniques. There are multiple modalities of optical imaging techniques, 
including optical coherence tomography, confocal reflectance microscopy, confocal fluorescence 
microscopy, fiber optic microendoscopy, and a variation of fiber optic microscopy that employs 
structured illumination.  
Optical coherence tomography (OCT) is a high resolution optical imaging modality 
which uses near-IR light as the light source for tissue illumination [88, 89]. Diverse scattering 
and absorption properties of different tissues provide endogenous contrast, so an exogenous 
contrast agent is unnecessary. OCT has been used in several studies to image human axillary 
lymph nodes and breast tumor margins [90-94]. McLaughlin et al. performed a study comparing 
OCT to histologic assessment for identification of metastatic cells in lymph nodes [90]. The 
results of this study showed that OCT was able to accurately distinguish lymph nodes from 
surrounding adipose tissue and identify evidence of metastatic cells in lymph nodes [90]. Nguyen 
et al. performed a 37 patient clinical study using OCT to assess breast tumor margins [91]. Based 
on comparison to histology, OCT had a sensitivity of 100% and a specificity of 82% for 
assessment of positive and negative tumor margins [91].  A multicenter, prospective study 
published by Zysk et al. in 2015 was performed to investigate the feasibility of using a handheld 
OCT probe to assess tumor margins following breast-conserving surgery and to evaluate 
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potential impact on the rate of reoperation. Of the 46 patients enrolled in the study, 8 patients had 
positive margins following breast-conserving surgery and the OCT device identified positive 
margins in 5/8 (63%) patients [94]. These results demonstrate that OCT can be used for real-time 
intraoperative assessment of breast tumor margins.  
Confocal microscopy is an emerging tool that may address the limitations of current 
histologic approaches by providing imaging of tissue architecture and morphology with 
subcellular resolution in real time without the need for extensive tissue processing. When used 
with targeted agents, it also may enable rapid assessment of biomarkers. Some advantages of 
using confocal microscopy as an alternative to histologic assessment include are the ability to 
acquire images at the point-of-care and to use either reflectance or fluorescence mode with 
multilaser systems providing the ability to excite more than one fluorescent label. Confocal 
reflectance microscopy has been shown to capture high-resolution images of cellular and nuclear 
morphological features [95]. Tilli and colleagues showed that acetic acid enhanced image detail 
in confocal reflectance images of mouse mammary and resected human breast tissue [96]. 
Confocal reflectance microscopy of core-needle breast biopsy specimens enabled measurements 
of nuclear size, all of which were found to be within published ranges. Comparison of confocal 
reflectance images with histologic images showed that confocal reflectance microscopy can 
distinguish benign and malignant breast tissue [96]. Confocal fluorescence microscopy has not 
been used previously to evaluate breast carcinoma specimens. However, it has been used in a 
few studies to image melanoma [97] and basal cell carcinoma in Mohs skin excisions [98].  
A simpler, cheaper and more portable alternative to confocal microscopy is high 
resolution microendoscopy (HRME). HRME is an optical imaging technique that, when coupled 
with an optical contrast agent, can obtain images of tissue in vivo with sub-cellular resolution in 
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precancerous and malignant lesions in the oral cavity, esophagus, and axillary lymph nodes [99-
101]. The light source for HRME is a blue light emitting diode (LED) with excitation 
wavelength centered at 455nm to excite the optical contrast agent, proflavine. Images are 
obtained with HRME by placing a coherent fiber bundle consisting of 30,000 fibers on the 
sample surface after topical application of proflavine (Figure 2-5). Light from the LED is 
transmitted through the fiber bundle to the sample where tissue stained by the contrast agent is 
excited by light from the LED. Fluorescence emission is collected by the fiber bundle and 
transmitted through a dichroic mirror to a CCD camera [101]. The HRME system has been 
utilized in several studies to image the oral cavity [101], Barrett’s esophagus [100], and axillary 
lymph nodes [99]. 
 
Figure 2-5: Optical diagram of the fiber optic micro-endoscope [Rosbach KJ et al. Biomed. Opt. Express, 2010][102]. 
Figure is from an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-
No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work 
is properly cited. 
However, a major limitation of image acquisition with HRME, particularly for highly 
scattering tissues, is low resolution relative to confocal laser scanning microscopy. Structured 
illumination microscopy [103] is an inexpensive alternative to confocal microscopy that 
addresses the limitation of low resolution by illuminating tissue samples with a periodic light 
pattern to achieve optical sectioning. A one-dimensional grid or a sine wave [104] pattern is 
projected onto the sample and is refocused at the excitation plane, from which image is acquired. 
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During this procedure, three fluorescence images are acquired at the same axial depth, from three 
different positions of the grid separated laterally by one third of the grid period [105, 106]. An 
optically-sectioned image is produced by combining the three raw images with the following 
algorithm:  
𝐼𝑆𝐼𝑀(𝑥) =  
1
3√2
√(𝐼1(𝑥) − 𝐼2(𝑥))2 + (𝐼2(𝑥) − 𝐼3(𝑥))2 + (𝐼3(𝑥) − 𝐼1(𝑥))2 [105] 
The three raw images are represented by the variables  𝐼1(𝑥), 𝐼2(𝑥), and 𝐼3(𝑥), and x designates a 
2D coordinate in the imaging plane [105]. Structured illumination microscopy has been used 
previously to detect cellular changes associated with cervical pre-malignant lesions [107]. A 
recent report described a high resolution microendoscope system using structured illumination 
microscopy (SI-HRME) and demonstrated the feasibility of using structured illumination 
microscopy to image thick samples with significant background signal [105]. Keahey et al. 
developed a portable structured illumination microendoscope system and quantified axial 
response of the system in optical phantoms in order to optimize modulation frequency. The 
optimized system was used to evaluate image contrast in ex vivo cervical columnar epithelium 
[108]. This system was also used to demonstrate the feasibility of structured illumination 
microendoscopy to evaluate response to treatment in murine mammary glands [109].  
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3 CHAPTER 3: Feasibility of confocal fluorescence microscopy for 
evaluation of neoplasia in fresh human breast tissue: outlining 
preliminary criteria for assessment of a confocal image library1 
 
ABSTRACT: Breast cancer management could be improved by developing real-time imaging 
tools to assess tissue architecture without extensive processing. We sought to determine whether 
confocal fluorescence microscopy provides sufficient information to identify neoplasia in breast 
tissue. Breast tissue specimens were imaged following proflavine application. Regions of interest 
(ROIs) were selected in histologic slides and in the corresponding region on confocal images 
then divided into sets for training and validation. Readers reviewed images in the training set and 
evaluated images in the validation set for the presence of neoplasia. Accuracy was assessed using 
histologic diagnosis as the gold standard. 70 tissue specimens from 31 patients were imaged; 235 
ROIs were identified and diagnosed as neoplastic or non-neoplastic. A training set was 
assembled using 23 matched ROIs; 49 matched ROIs were assembled into a validation set. 
Neoplasia was identified in histologic images: 93% sensitivity, 97% specificity (Area under the 
curve, AUC=0.987) and confocal images: 93% sensitivity, 93% specificity (AUC=0.957). 
Confocal fluorescence microscopy produced images of architectural features in breast tissue 
comparable to conventional histology while requiring little processing. Potential applications 
include assessment of excised tissue margins and evaluation of tissue adequacy for bio-banking 
and genomic studies. 
 
                                                          
1 The contents of this chapter have been published in the following journal article: Dobbs JL, Ding H, Benveniste 
AP, Kuerer HM, Krishnamurthy S, Yang W, Richards-Kortum R. Feasibility of confocal fluorescence microscopy 
for real-time evaluation of neoplasia in fresh human breast tissue. J Biomed Optics 2013; 18(10), 106016. (Oct 28, 
2013). ; http://dx.doi.org/10.1117/1.JBO.18.10.106016 © The Authors. Published by SPIE under a Creative 
Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires 
full attribution of the original publication, including its DOI. 
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3.1  Introduction 
Approximately 1 in 8 women in the United States will develop breast cancer in their 
lifetime [110]. An estimated 207,000 new cases of breast cancer will be diagnosed in the United 
States in the next year, and approximately 40,000 U.S. women will die of this disease in the 
same period [111]. Currently, histologic assessment is the gold standard for differentiating 
neoplastic from non-neoplastic lesions to diagnose breast cancer.  However histologic 
assessment has limitations, including the requirement for extensive tissue processing, and it takes 
several days to complete preparation before samples can be assessed by pathologists. 
Furthermore, if cores or tissue excised are inadequate for clinical diagnosis or research 
applications, an additional tissue excision procedure must be performed. Frozen section 
pathology can be performed the same day as tissue excision [26, 112]; however, frozen section 
has shown to be limited by sampling variability, which can lead to false negatives [113, 114]. 
Breast pathology experts in the United States [115] and Europe [116, 117] do not recommend 
frozen section for breast lesions which cannot be identified by macroscopic examination, are 
smaller than 10 mm in size, and for which a preoperative diagnosis is not possible [115, 116, 
118]. Fine needle aspiration cytology (FNA) can also be used for rapid breast lesion assessment 
[113, 116], but does not preserve tissue architecture in the context of the lesion 
microenvironment. There is a need for a rapid technique that provides high resolution 
morphologic detail to differentiate neoplastic from non-neoplastic breast lesions in real-time to 
inform management of breast disease. 
Confocal microscopy is an emerging tool that may address the limitations of current 
histologic approaches by providing images of tissue architecture and morphology with 
subcellular resolution in real time without the need for extensive tissue processing [96, 98, 119-
121]. Confocal fluorescence images can be obtained in either reflectance or fluorescence mode. 
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When used following topical application of acetic acid, confocal reflectance microscopy can be 
used to acquire high-resolution images of excised breast tissue that reveal cellular and nuclear 
morphological features characteristic of neoplasia [95]. Application of proflavine enhances 
contrast in confocal images by staining DNA within nuclei. Proflavine was recently used as an 
optical contrast agent to assess Barrett’s esophagus and axillary lymph nodes [99, 100, 122], and 
results from these studies demonstrate that fluorescence microscopy with proflavine yields 
images with morphologic detail that is visually comparable to that of histologic sections. 
The goal of this work was to determine whether confocal fluorescence images of fresh human 
breast tissue provide sufficient information to enable discernment of neoplastic and non-
neoplastic breast features.  To achieve this goal, we characterized the microscopic features of 
normal, benign and neoplastic breast biopsies visible using confocal microscopy, and assessed 
diagnostic accuracy using these features compared to the gold standard of histology.  
3.2  Materials and Methods 
Patients were eligible for the study if they were undergoing surgery for breast cancer or 
ultrasound-guided core needle breast biopsy for untreated, newly diagnosed inflammatory breast 
cancer [123]. The study protocol was reviewed and approved by the institutional review boards 
of The University of Texas MD Anderson Cancer Center and Rice University, and each 
participant gave written informed consent. Thirty-one patients with known primary breast cancer 
who presented for imaging staging or for surgery agreed to participate in the study between 
November 2010 and February 2012. A total of 70 tissue specimens were collected: 62 specimens 
were obtained from 23 patients who underwent a surgical excision procedure and 8 specimens 
were obtained from 8 patients who underwent a core-needle biopsy procedure. Of the specimens 
imaged, 25 consisted of normal or benign tissue, 11 were diagnosed as ductal carcinoma in situ, 
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19 as invasive ductal carcinoma, 13 as invasive lobular carcinoma, and 2 as mucinous 
carcinoma. 
For surgical specimens, two specimens (approximately 15 u 15 mm in size, with 
thickness varying between 2-7 mm) were taken from excised tissue within 10 minutes of 
resection; one specimen was selected from a grossly normal-appearing region and the other from 
an area that appeared grossly to contain neoplastic tissue. For core-needle biopsy specimens, a 
single core of breast tissue was obtained within 5 minutes of the procedure; core biopsy 
specimens were typically 1 u 4 u 12 mm3 in size. Specimens were kept moist in isotonic PBS 
(pH = 7.4) prior to imaging. Imaging was performed in vitro within 10 minutes of tissue 
removal.  The superficial cell layers of fresh tissue specimens were stained before imaging by 
applying 0.01% proflavine in sterile PBS to the surface for 1 minute [124]. Proflavine is a 
fluorescent topical antiseptic; it preferentially stains nuclei and has been used previously as a 
contrast agent for fluorescence confocal microscopy [100, 122]. Proflavine has an excitation 
maximum of 460 nm and an emission maximum of 530 nm. After staining, tissue specimens 
were washed for 1 minute in isotonic PBS. A white-light photograph was taken with a digital 
camera to record tissue shape and gross appearance. 
Confocal fluorescence images of each specimen were obtained using a scanning confocal 
microscope (Vivascope 2500®; Caliber Imaging and Diagnostics Inc., Rochester, NY). Images 
were obtained at 488 nm excitation with a 550nm ± 44 nm bandpass filter using a 30X water 
immersion objective lens with a numerical aperture of 0.8. At these settings, the lateral resolution 
was 1.0 µm at the center of the region of interest (ROI), the axial resolution was 5.0 µm at the 
center of the ROI, and the ROI was 750 u 750 µm. Images were acquired at a frame rate of 9 
frames per second.  
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Tissue specimens were positioned on the microscope stage. The imaging depth was set to 
acquire images from the superficial cell layers of the tissue specimen and up to 60 µm into the 
tissue surface.  Illumination power was initially set to 2.0 mW (r 0.4 mW) and manually 
adjusted to maximize signal while avoiding saturation. For the surgical specimens, the stage was 
scanned to obtain images from adjacent ROIs at the same axial depth in a grid pattern to create a 
composite image with a maximum area of 12.2 u 12.2 mm. For the core-needle biopsy 
specimens, the composite images comprised the surface of the entire specimen; approximately 4 
u 12.2 mm. For each specimen, a series of three composite images was acquired at three 
different axial depths in increments of 20 µm beneath the surface. Total imaging time for each 
specimen was approximately 10 minutes. After imaging, each specimen was placed in a tissue 
cassette, fixed in 10% buffered formalin, and submitted for routine processing and histologic 
assessment by a dedicated breast pathologist.  
Composite confocal images were visually compared to images of hematoxylin and eosin 
(H&E)–stained tissue sections at 4X magnification to identify ROIs with similar prominent 
architectural features. Confocal and histologic images of these areas were examined at higher 
magnification; single 750 u 750-µm ROIs obtained with the confocal microscope were compared 
to histologic images at 10X magnification (Fig. 1). Matched ROIs containing features that had 
similar appearances in the histologic slides and the corresponding confocal microscopy images 
were selected by two observers blinded to the histologic diagnosis (HD, JD); a board-certified, 
dedicated breast pathologist (SK) reviewed the H&E–stained image of each of these matched 
ROIs and provided a diagnosis using standard histologic criteria [15]. The confocal images of the 
matched ROIs were examined and compared to the corresponding histologic image to establish 
which features of neoplastic and non-neoplastic breast tissues could be imaged using confocal 
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fluorescence microscopy with proflavine staining; the procedure for identifying matching ROIs 
is shown in Figure 3-1. The matched ROIs were used to assess the ability of pathologists to 
identify the presence of neoplasia in a confocal fluorescence image. 
 
Figure 3-1: Schematic of the procedure used to identify matching regions of interest within images acquired by the 
confocal fluorescence microscopy system (top right, left, and center) and conventional histology (bottom right, left, and 
center). The two center images are low-resolution images of the entire breast core biopsy specimen. The high-resolution 
images at left represent a region of tissue exhibiting histologic transition from normal to neoplastic (invasive ductal 
carcinoma). The high-resolution images at right represent a region of tissue with invasive carcinoma. Scale bars are 1.5 
mm for the low-resolution images and 100 µm for the high-resolution images. 
 
To investigate the intensity of proflavine staining vs. histologic diagnosis, the mean 
fluorescence intensity was calculated for a representative group of ROIs from each diagnostic 
category. Confocal fluorescence images were manually segmented to isolate regions with 
morphology of interest, including non-hyperplastic ducts, hyperplastic ducts, ductal carcinoma in 
situ, and invasive ductal carcinoma. Fluorescence intensity was normalized by the laser power 
used for image acquisition and a mean fluorescence intensity value was measured for each region 
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by calculating the average pixel brightness over the area of the region. Statistical analysis of 
mean fluorescence intensity was performed using Student’s t-test.  
To compare the performance of confocal fluorescence microscopy and conventional 
histology, a validation study was performed using corresponding confocal and histologic images 
to calculate the sensitivity and specificity of these techniques for distinguishing between 
neoplastic and non-neoplastic breast features. A subset of matched confocal and histologic 
images was selected for use as a training set; these images were displayed side-by-side to 
familiarize readers with features of neoplasia visible in confocal fluorescence images. A subset 
of the remaining matched ROIs were used to create a validation set to compare the ability of 
readers to identify the presence of neoplasia in either confocal fluorescence images or standard 
histologic images. Readers first reviewed the training set for approximately 10 minutes. Readers 
were then asked to review histologic and confocal fluorescence images in the validation study 
based on standard histologic criteria and to use criteria presented in the training set to assist with 
review of confocal fluorescence images. Readers ranked images on a scale of 1-5 (1 = normal 
tissue or non-proliferative adipocytes, collagen, lobules, and ducts; 2 = indecisive between 
normal and benign changes; 3 = benign changes such as mild hyperplasia, chronic inflammation, 
fibrocystic changes and fibrosis; 4 = indecisive between benign changes and neoplasia; 5 = 
neoplastic tissue including ductal carcinoma in situ, invasive ductal carcinoma, and invasive 
lobular carcinoma). Both confocal fluorescence and histology images in the validation study 
were presented in random order. Accuracy was assessed relative to diagnosis by histology, which 
was made by a certified, dedicated breast pathologist (SK).  
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3.3  Results 
A total of 235 unique ROIs were identified in the confocal fluorescence images that could 
be matched to an ROI in the corresponding standard histologic slide; a summary of patients, 
specimens, and ROIs from which data were acquired is shown in Table 3-1. Forty-nine ROIs 
showed histologically normal, non-neoplastic breast tissue. Figure 3-2 shows representative 
confocal fluorescence images of normal breast features with images of corresponding features 
identified in conventional histologic slides: adipocytes, collagen, blood vessels, ducts, and 
lobular units. Both confocal fluorescence images and conventional histologic images show 
closely packed adipocytes (Figure 3-2A, F). In confocal images, adipocytes exhibit weak 
proflavine staining of the pericellular nuclei, moderate staining of the cell membranes, and no 
staining of the lipid droplets within the cytoplasm (Figure 3-2F). Confocal fluorescence images of 
extracellular matrix are characterized by brightly stained fibroblast nuclei interspersed 
throughout bundles of collagen fibers, which exhibited weak proflavine staining (Figure 3-2B, G). 
Blood vessels are easily recognized in confocal fluorescence images; the nuclei of the 
endothelial cells are stained moderately with proflavine and arranged around a dark lumen 
(Figure 3-2C, H). Confocal fluorescence images of individual ducts show weakly stained 
myoepithelial and columnar cell nuclei that surround an unstained lumen (Figure 3-2D, I). 
Confocal and histologic images show cells arranged in acini to form terminal ductal lobular units 
(TDLU, Figure 3-2E, J). Confocal fluorescence images of lobules are characterized by intensely 
stained epithelial cell nuclei (Figure 3-2J).  
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Table 3-1: Summary of patients, specimens, and ROIs. *Non-neoplastic specimens contained sites with normal histologic 
features observed in the breast and features representative of benign changes. 
 # ROI 
Patients 31  
Surgical tissue excision 23  
Core biopsy 8  
All specimens 70 235 
Surgical tissue excision 62 208 
Core biopsy 8 27 
Non-neoplastic specimens 25 110 
Normal 25* 49 
Benign changes 25* 61 
Neoplastic specimens 37 125 
Ductal carcinoma in situ 11 27 
Invasive ductal carcinoma 19 66 
Invasive lobular carcinoma 13 28 
Mucinous carcinoma 2 4 
 
 
Figure 3-2: Normal, non-neoplastic breast architectural features (from left): adipocytes (A, F), collagen (B, G), blood 
vessel (C, H), ducts (D, I), and lobules (E, J). A-E: Architectural features in human breast tissue specimens prepared 
according to standard histologic technique with H&E staining. F-J: Architectural features from the same fields of view as 
A-E imaged with confocal fluorescence microscopy. Scale bar is 100 µm. 
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Sixty-one ROIs showed breast features considered to be non-neoplastic benign changes. 
Figure 3-3 shows representative confocal images of benign breast features with corresponding 
standard histologic images: chronic inflammation, fibrosis, mild hyperplasia, and fibrocystic 
changes. Chronic inflammation is identified in histologic images by the increased number of 
lymphocytes (Figure 3-3A). On corresponding confocal images, chronic inflammation is 
characterized by clusters of small, intensely stained inflammatory cell nuclei (Figure 3-3E). 
Fibrosis in confocal and histologic images is associated with an increased number of fibroblasts 
diffusely distributed throughout the stroma (Figure 3-3B, F). Confocal images of ROIs with 
fibrosis show fibroblasts with intensely stained nuclei interspersed throughout weakly stained 
collagen fibers in the stroma (Figure 3-3F). Mild ductal hyperplasia without atypia was identified 
in histologic images by an increase in number of cells lining a ductal space (Figure 3-3C, G). This 
increase in cell number is also evident in confocal images, where the columnar cell nuclei are 
weakly stained with proflavine (Figure 3-3G). Confocal and histologic images of sclerosing 
adenosis, a hallmark of fibrocystic changes, show distortion of acini with stromal fibrosis in 
TDLUs (Figure 3-3D, H). Sclerosing adenosis is identified in confocal images by small, weakly 
stained cuboidal cell nuclei that formed distorted acinar structures (Figure 3-3H).  
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Figure 3-3: Benign, non-neoplastic breast architectural features (from left): Inflammation (A,E), fibrosis (B,F), mild 
hyperplasia without atypia (C,G), and fibrocystic changes (D,H). A-D: Architectural features in human breast tissue 
specimens prepared according to standard histologic technique with H&E staining. E-H: Architectural features from the 
same fields of view as A-E imaged with confocal fluorescence microscopy. Scale bar is 100 µm. 
 
One hundred and twenty-five ROIs showed histologically neoplastic breast tissue. Figure 
3-4 shows representative confocal and histologic images including neoplastic features: ductal 
carcinoma in situ, invasive ductal carcinoma, and invasive lobular carcinoma. Ductal carcinoma 
in situ was identified in histologic and confocal images by disorganized cell proliferation in ducts 
with no invasion into the surrounding stroma (Figure 3-4A, D). Invasive ductal carcinoma was 
characterized in histologic images by disorganized invasion of ductal carcinoma cells into stroma 
(Figure 3-4B). In confocal fluorescence images, invading ductal carcinoma cells show large, 
pleomorphic, weakly stained nuclei (Figure 3-4E). Invasive lobular carcinoma was characterized 
in histologic images by lobular carcinoma cells invading single-file into stroma (Figure 3-4C). 
These cells are easily identified in confocal fluorescence images, which show single-file 
invading cells with enlarged, intensely stained nuclei (Figure 3-4F).  
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Figure 3-4: Neoplastic breast architectural features (from left): ductal carcinoma in situ (A,D), invasive ductal carcinoma 
(B,E) and invasive lobular carcinoma (C,F). A-C: Architectural features in human breast tissue specimens prepared 
according to standard histologic technique with H&E staining. D-F: Architectural features from the same fields of view as 
A-B imaged with confocal fluorescence microscopy. Scale bar is 100 µm. 
 
The representative images of normal, benign, and neoplastic features (Figure 3-2, Figure 
3-3, Figure 3-4) demonstrate that confocal fluorescence images capture a wide range of histologic 
features of the breast, which can be observed using standard histology. Confocal images were 
grouped into three categories based on histologic diagnosis: normal, benign, and neoplastic. 
Images in each category were reviewed to characterize the following features: 1) cell architecture 
and orientation, 2) nuclear spacing, 3) nuclear size, and 4) intensity of proflavine fluorescence. 
The confocal image features of each category were compiled into a lexicon by tissue diagnosis 
(Figure 3-5 and Figure 3-6).  
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Figure 3-5: Normal and benign breast architectural features imaged by confocal fluorescence microscopy. Normal breast 
architectural features (left column): adipocytes, collagen, blood vessels, ducts, and lobules. Architectural features of 
benign changes in the breast tissue (right column): inflammation, stromal fibrosis, stromal multinucleated giant cells, 
mild hyperplasia with no atypia, and fibrocystic changes. Each feature is described by four criteria, which can be used to 
aid in interpretation of images acquired with confocal fluorescence microscopy: cell architecture, internuclear distance, 
nuclear size, and nuclear staining characteristics. Scale bars are 100 µm. 
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Figure 3-6: Neoplastic breast architectural features imaged by confocal fluorescence microscopy. Neoplastic breast 
architectural features: ductal carcinoma in situ, invasive ductal carcinoma, and invasive lobular carcinoma. Each feature 
is described by four criteria which can be used to aid in interpretation of images acquired with confocal fluorescence 
microscopy: cell architecture, internuclear distance, nuclear size, and nuclear staining characteristics. Scale bars are 100 
µm.  
 
Mean fluorescence intensity was measured at ROIs in confocal fluorescence images 
illustrating non-neoplasia: normal, non-hyperplastic ducts (n=36) and ductal hyperplasia (n=17), 
and neoplasia: ductal carcinoma in situ (n=12) and invasive ductal carcinoma (n=25). To ensure 
that mean fluorescence intensity was assessed in a representative set of samples, we measured 
mean fluorescence intensity in ROIs that were included in the training and validation sets and in 
additional ROIs identified in confocal fluorescence images of specimens summarized in Table 
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3-1. The histologic diagnosis for all additional ROIs identified in confocal fluorescence images 
and assessed for mean fluorescence intensity was verified by a dedicated breast pathologist. 
Figure 3-7 shows the mean fluorescence intensity by diagnostic category. The mean fluorescence 
intensity reported in Figure 3-7 supports the descriptors provided in Figure 3-5 and Figure 3-6. The 
mean fluorescence intensity of DCIS (intensely stained nuclei) is higher than IDC, normal ducts, 
and hyperplastic ducts, all described with weakly stained nuclei. Differences in the mean 
fluorescence intensity of DCIS are statistically significant when compared to that of IDC (p = 
0.007) and non-neoplastic ducts (p = 0.015). Mean fluorescence intensity values observed in 
normal ducts (26.6 ± 9.9), ductal hyperplasia (29.3 ± 8.2) and invasive ductal carcinoma (25.9 ± 
8.8) were not significantly different (p > 0.05).  
 
Figure 3-7: Mean fluorescence intensity measured in confocal fluorescence images at ROIs with non-neoplasia: normal, 
non-hyperplastic ducts (n= 36), ductal hyperplasia (n=17), and neoplasia: ductal carcinoma in situ (n=12), and invasive 
ductal carcinoma (n=25).   
 
50 
 
Matched confocal and histology images were assembled into a training and validation set 
to compare the diagnostic performance of confocal fluorescence microscopy and standard 
histology in distinguishing between neoplastic and non-neoplastic features. Matched pairs of 
confocal and histology images acquired from 23 sites were used to train readers to review 
confocal images based on characteristics including morphology, staining, and nuclear size 
(Figure 3-5 and Figure 3-6). From the remaining images, 98 images of 49 matched ROIs were 
separated into groups of confocal and histologic images, which were randomly ordered in the 
validation set. A total of 7 readers, 5 pathologists and 2 cytopathology fellows (Department of 
Pathology, MDACC), underwent training and reviewed validation images.   
Table 3-2 illustrates the results of visual assessment of images acquired by histology with 
H&E staining (Table 3-2A) and confocal fluorescence microscopy (Table 3-2B). Results are 
organized based on the rankings assigned to the images in the validation set by each reader and 
by the true histologic diagnosis for each image as determined by a board-certified breast 
pathologist. Sensitivity and specificity of evaluation of confocal fluorescence images and 
conventional histologic images were calculated based on each reader’s review of the validation 
images; neoplasia was classified by a ranking of 4 or 5, non-neoplasia was classified by a 
ranking of 1-3. 
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Table 3-2: Results of visual assessment of images in the validation study. The total number of rankings, 343, is based on 
the rankings assigned by 7 pathologists to each of the 49 images in the validation set. Each validation set included 18 
images with histologically normal breast morphology, 10 images that showed morphology with benign changes, and 21 
images with neoplastic breast morphology; when the images were ranked by all 7 readers, this resulted in 126 rankings 
for normal ROIs, 70 rankings for ROIs with benign changes, and 147 rankings for ROIs with neoplasia.  False positives 
were classified as images whose true histologic diagnosis was normal or benign changes, but which were assigned a 
ranking of 4 or 5. Similarly, false negatives were designated as images with a diagnosis of neoplasia, which were assigned 
a ranking of 1-3. 
 
Table 3-3 gives a summary of each reader’s performance in reviewing images in the 
validation set. In Figure 3-8, a receiver operator characteristic (ROC) curve shows the averaged 
performance of all readers in distinguishing neoplastic from non-neoplastic breast cellular 
features. At the Q-point for the histology ROC curve (square markers, solid line), sensitivity is 
93% and specificity is 97% with an area under the ROC curve of 0.987, and at the Q-point for 
the confocal fluorescence microscopy ROC curve, sensitivity is 93% and specificity is 93% with 
an area under the ROC curve of 0.957. When accuracy is assessed based on experience level, the 
readers with more experience in image review (pathologists A-E) have higher accuracy in 
identifying neoplasia than those with less experience (pathology fellows A and B). Pathologists 
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and pathology fellows assigned twice the number of false positive rankings in confocal 
fluorescence images than in H&E images. Readers assigned false negative rankings to the same 
number of sites in confocal fluorescence and H&E images. In both types of images, DCIS, IDC, 
and ILC sites were assigned false negative rankings. There were twice as many sites identified as 
false positives in confocal fluorescence images than in H&E images. More than half of the false 
positive rankings assigned to confocal fluorescence images were given to sites with normal 
lobules, however the highest number of false positive rankings was assigned to a single confocal 
fluorescence image of inflammation (classified incorrectly by 4/7 readers).  
Table 3-3: Summary of reader accuracy in distinguishing neoplastic from non-neoplastic breast cellular features in 
conventional histologic and confocal fluorescence images. When the results are separated based on reader experience in 
image review, the averaged sensitivity and specificity values are higher for readers with more experience (pathologists A-
E) than readers with less experience (pathology fellows A and B).  FP = false positive rankings assigned; FN = false 
negative rankings assigned. 
 Histology Confocal Fluorescence Microscopy 
 FN FP Sensitivity Specificity FN FP Sensitivity Specificity 
Pathologist A 0 1 100% 96% 2 0 90% 100% 
Pathologist B 0 2 100% 93% 0 3 100% 89% 
Pathologist C 2 1 90% 96% 2 1 90% 96% 
Pathologist D 1 0 95% 100% 0 2 100% 93% 
Pathologist E 1 0 95% 100% 1 4 95% 86% 
Pathology Fellow A 3 1 86% 96% 3 0 86% 100% 
Pathology Fellow B 4 1 81% 96% 3 3 86% 89% 
All Readers 11 6 93% (±8%) 97% (±2%) 11 13 93% (±5%) 93% (±6%) 
Pathologists 4 4 96% (±4%) 97% (±3%) 5 10 95% (±5%) 93% (±8%) 
Pathology Fellows 7 2 83% 96% 6 3 86% 95% 
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Figure 3-8: Receiver operator characteristic (ROC) curve for the averaged performance of all readers in distinguishing 
neoplastic from non- neoplastic breast architectural features in conventional histologic (square markers, solid line) and 
confocal fluorescence images (triangular markers, dashed line). At the Q-point of the ROC curve for histology 
performance, the sensitivity is 93% and the specificity is 97% with an area under the ROC curve of 0.987. At the Q-point 
of the ROC curve for confocal fluorescence microscopy performance, the sensitivity is 93% and the specificity is 93% 
with an area under the ROC curve of 0.957.  
 
We calculated a Kappa score to evaluate inter-rater agreement for visual assessment of 
H&E and confocal fluorescence images. Since there were 7 raters who assigned rankings to 
images, we used a formula developed to calculate a Kappa score for multiple ratings per subject 
[125]. The Kappa score for raters’ agreement when ranking H&E images is 0.63 and the Z test 
statistic is 30.0 (p<0.001). When ranking CFM images, inter-rater agreement is characterized by 
a Kappa score of 0.51 and a Z test statistic of 24.6 (p<0.001). Landis and Koch described the 
ranges of kappa statistic values in intervals of 0.2 from 0 to 1 (where kappa values of 1 and 0 
indicate perfect agreement and agreement that could occur by chance, respectively), which are 
commonly used for kappa statistic interpretation [55, 126-128]. The ranges of kappa statistic 
values 0.41-0.60 and 0.61-0.80 indicate moderate and substantial agreement strengths, 
respectively.  
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3.4 Discussion 
The objective of this work was to determine if assessment of breast architecture in confocal 
fluorescence microscopy images has similar performance to assessment of histologic slides with 
H&E staining without the need for extensive tissue processing. The findings of this study show 
that confocal fluorescence images of fresh human breast tissue stained topically using proflavine 
provide sufficient information to enable discernment of neoplastic and non-neoplastic breast 
features.   
Histology slides are produced through an intricate, time-intensive process. Tissue 
specimens are fixed through immersion in a chemical fixative to prevent cell autolysis and 
degradation; adequate tissue fixation takes approximately 24-48 hours. After fixation, tissue 
specimens are dehydrated through immersion in alcohol to remove excess water and formalin, 
alcohol is removed from tissue, and specimens are infiltrated with an embedding agent such as 
paraffin wax. After the wax solidifies, a microtome is used to cut the tissue specimen into 5 µm 
thick sections. Excess wax is melted off over a few hours, and then a histochemical stain such as 
hematoxylin and eosin (H&E) is applied. Complete preparation of histologic slides is costly and 
delays assessment and diagnosis by 1 to 2 days.  
Confocal fluorescence microscopy offers a number of important potential advantages as 
an imaging tool. Sample preparation for confocal fluorescence microscopy is fast and simple. 
Fresh, unprocessed tissue specimens are stained for 1 minute then washed to remove excess dye. 
The specimen is then imaged with no further processing and without the need for fixation, 
embedding, or sectioning. The camera in the microscope is integrated into the system hardware, 
allowing for image acquisition at near video rate; a 12.2 X 12.2 mm specimen can be imaged 
using confocal fluorescence microscopy in 10 minutes, and imaging a 4 X 12 mm core needle 
55 
 
biopsy requires less than 2 minutes. Portable confocal microscopes with real-time imaging 
capability are now commercially available. 
A number of other optical imaging modalities have been explored for real-time imaging 
of breast tissue.  Optical coherence tomography (OCT) has been evaluated in several studies for 
real-time, intraoperative assessment of lymph nodes and breast tumor margins [90, 91, 93], but 
the resolution of OCT has been too low to provide sufficient detail for rapid tissue assessment. 
While higher resolution OCT systems are in development, the greater axial resolution of 
confocal fluorescence microscopy enables resolution of cellular and nuclear features comparable 
to that of high-magnification (u40) light microscopic images of thin sections. Confocal 
reflectance microscopy offers resolution similar to that of confocal fluorescence microscopy. 
Tilli and colleagues showed that acetic acid enhances image detail in confocal reflectance images 
of mouse mammary and resected human breast tissue, which enabled measurements of nuclear 
size. Their work demonstrated that near-infrared reflectance confocal microscopy images of 
mouse mammary and human breast tissue morphology correlate to histologic images with H&E 
staining [96].  
The work described here was performed as a small study to determine the features of 
neoplastic and non-neoplastic breast tissue that could be assessed at sample acquisition in a 
routine clinical setting using confocal fluorescence microscopy. All specimens were acquired at 
a single center, and only a small number of observers participated in image assessment. Further 
studies are necessary to determine whether confocal fluorescence images contain sufficient detail 
to enable diagnosis.  
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If confocal fluorescence images prove adequate for evaluation of breast tissue specimens, 
this technique could be useful in a number of clinical scenarios. A potentially significant clinical 
application of this platform is immediate evaluation of the adequacy of tissue core biopsy 
specimens procured with or without imaging guidance. The current technique of touch 
preparation of core biopsies does not ensure adequate representation of the targeted lesion for 
subsequent morphological, phenotypic, and molecular characterization [129]. A second potential 
application for this technique is rapid assessment of tumor margin status, which could be 
performed without the necessity for extensive tissue preparation while yielding results 
comparable to those of frozen section histology. Third, confocal microscopy could be useful to 
ensure procurement of adequate viable tumor tissue for molecular testing.  The ability to image 
tissue morphology with minimal specimen preparation could be valuable in the era of 
sophisticated and detailed molecular analysis, including genomic sequencing, for purposes of 
developing targeted and personalized therapy. Other possible applications for confocal 
microscopy include assessment of adequate tissue specimens in bio-banking, assistance in 
identifying desired cell types for use in cell culture, and facilitation in identifying suitable tissue 
for genomic or proteomic studies. Finally, this technique may be useful to provide histologic 
diagnosis in low-resource settings where infrastructure for traditional histologic preparation is 
not available [130].  
In conclusion, we present the results of an observational study comparing images 
acquired with minimal tissue processing using confocal fluorescence microscopy to identify 
characteristics of a wide range of neoplastic and non-neoplastic breast lesions. Confocal 
fluorescence microscopy can be performed inexpensively and at near video rate with optimal 
preservation of the entire tissue for any kind of subsequent analysis. High resolution images 
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acquired using confocal fluorescence microscopy have micron resolution allowing evaluation of 
nuclear features and cell morphology, which correlate to those observed in histologic images 
with H&E staining. In the validation study, image review based on visual assessment shows that 
confocal fluorescence microscopy and standard histology had similar sensitivity and specificity 
values for distinguishing between neoplasia and non-neoplasia. The potential utility of this 
platform for different types of clinical and research applications needs to be tested in larger 
studies.   
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4 CHAPTER 4: Confocal fluorescence microscopy for rapid 
evaluation of invasive tumor cellularity of inflammatory breast 
carcinoma core needle biopsies2 
 
ABSTRACT: Tissue sampling is a problematic issue for inflammatory breast carcinoma, and 
immediate evaluation following core needle biopsy is needed to evaluate specimen adequacy. 
We sought to determine if confocal fluorescence microscopy provides sufficient resolution to 
evaluate specimen adequacy by comparing invasive tumor cellularity estimated from standard 
histologic images to invasive tumor cellularity estimated from confocal images of breast core 
needle biopsy specimens. Grayscale confocal fluorescence images of breast core needle biopsy 
specimens were acquired following proflavine application. A breast-dedicated pathologist 
evaluated invasive tumor cellularity in histologic images with hematoxylin and eosin staining 
and in grayscale and false colored confocal images of cores. Agreement between cellularity 
estimates was quantified using a kappa coefficient.  23 cores from 23 patients with suspected 
inflammatory breast carcinoma were imaged. Confocal images were acquired in an average of 
less than 2 minutes per core. Invasive tumor cellularity estimated from histologic and grayscale 
confocal images showed moderate agreement by kappa coefficient: κ = 0.48 ± 0.09 (p < 0.001). 
Grayscale confocal images require less than 2 minutes for acquisition and allow for evaluation of 
invasive tumor cellularity in breast core needle biopsy specimens with moderate agreement to 
histologic images. We show that confocal fluorescence microscopy can be performed 
                                                          
2 The contents of this chapter have been published in the following journal article: Dobbs J, Krishnamurthy S, 
Kyrish M, Benveniste AP, Yang W, Richards-Kortum R. Confocal fluorescence microscopy for rapid evaluation of 
invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies. Breast Cancer Res Treat 2015; 
149(1):303-10. This article is distributed under the terms of the Creative Commons Attribution Noncommercial 
License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original 
author(s) and the source are credited. 
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immediately following specimen acquisition and could indicate the need for additional biopsies 
at the initial visit.  
4.1 Introduction 
Inflammatory breast carcinoma (IBC) is a rare, aggressive type of breast cancer that is 
characterized clinically by tenderness, erythema, and edema involving at least one third of the 
entire breast [1, 123, 131, 132].  This variant of breast cancer can be clinically mistaken for 
mastitis and treated with antibiotics resulting in delay in the recognition of malignancy.  The 
redness and edema of the breast is attributed to the frequent involvement of the lymphovascular 
channels in the breast.  Pathologic diagnosis can be made using skin punch biopsy and / or core 
needle biopsy (CNB) of the affected breast.   The presence of lymphovascular tumor emboli in 
the skin biopsy and invasive mammary carcinoma in the core biopsy can establish the diagnosis 
and initiate the clinical management of the patients.  Tissue sampling can be a particularly 
problematic issue in IBC, since most cases present with no discrete mass and therefore accurate 
targeting of the area of breast for image-guided CNBs can be difficult [133, 134]. Shah and 
colleagues showed that sampling error can lead to inadequate CNB specimens, which have an 
insufficient amount of tissue to make a diagnosis, in as many as 9.1% of cases [135]. In cases 
with sampling error, several more days are required to perform repeated biopsies and histologic 
assessment for additional tissue specimens [135, 136]. Immediate evaluation of CNBs for 
assessment of tumor cellularity can be extremely valuable to ensure procurement of adequate 
tissue not just for diagnosis of the invasive carcinoma but also for ancillary studies in one setting.  
Touch preparation and frozen section are the currently available techniques for rapid evaluation 
of breast CNB specimen adequacy.  While touch preparation of breast CNBs can be useful to 
ascertain the presence or absence of tumor cells in the CNBs, it cannot indicate the extent of 
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tumor cellularity in the CNB and whether the malignancy is in situ, invasive, or both. In addition, 
the process of touching and rolling the CNBs on the glass slides may cause distortion, which 
makes them less than optimal for accurate histopathological examination. Frozen section is 
generally not preferred for immediate assessment of CNBs because of loss of the precious tissue 
during the cutting process. A technique is needed to evaluate the adequacy of IBC CNB 
specimens as soon as they are procured in a clinical setting, without tissue preparation that may 
compromise the quality of the core.  The technique should be able to immediately indicate to the 
radiologist if the area of interest has been accurately targeted, and if additional biopsies are 
required [135].  
Several studies have established the utility of confocal microscopy for breast tissue 
assessment [1, 96, 120, 121, 137]. Schiffhauer and colleagues demonstrated the feasibility of 
confocal reflectance microscopy for identifying the presence of neoplasia in unfixed breast CNB 
specimens in real time [121]. We recently showed that confocal fluorescence microscopy can be 
performed in a clinical setting to acquire images of fresh breast tissue with sufficient resolution 
to identify neoplastic and non-neoplastic breast cytomorphological and architectural features [1].  
The objective of this work was to determine the feasibility of using confocal fluorescence 
microscopy in a clinical setting to evaluate the adequacy of IBC CNB specimens by estimating 
the amount of invasive tumor cellularity in each specimen. To meet this objective, we performed 
a proof of concept study to estimate invasive tumor cellularity from grayscale confocal images 
and confocal images that were false colored to mimic histologic staining; results were compared 
to the assessment from the gold standard of histologic images obtained from conventional light 
microscopic examination of formalin fixed and paraffin embedded tissue sections of the core 
biopsies stained by hematoxylin and eosin.  
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4.2  Materials and Methods 
Core needle biopsy specimens were obtained from patients with clinical signs and 
symptoms of IBC. The protocol for tissue acquisition was reviewed and approved by the 
Institutional Review Boards at The University of Texas MD Anderson Cancer Center and Rice 
University. Ultrasound-guided CNBs were performed per standard clinical protocol. Single cores 
were prepared for confocal imaging within 5 minutes of the core needle biopsy procedure; each 
core was typically 1 x 4 x 12 mm3 in size. Cores were kept moist in phosphate buffered saline 
(PBS) (pH = 7.4) prior to imaging. A solution of 0.01% proflavine in sterile PBS was applied 
topically to the core for approximately 1 minute; proflavine is a fluorescent dye that 
preferentially stains nuclei in confocal fluorescence images [100, 102, 122, 138].  
The procedure for imaging cores with confocal fluorescence microscopy has been 
described previously [1]. Prior to imaging, a core was positioned on the microscope stage. Each 
core was imaged using a scanning confocal microscope (Vivascope 2500®; Caliber Imaging and 
Diagnostics Inc., Rochester, New York) at 488 nm excitation with a 550 ± 44 nm bandpass filter 
with a 30x water immersion lens (numerical aperture = 0.8). At the center of the 750 x 750 µm2 
region of interest (ROI), lateral resolution of the confocal microscope is 1.0 µm and axial 
resolution is 5.0 µm. Initially, illumination power was set to 2.1 mW (± 0.4 mW) and adjusted to 
maximize signal and avoid saturation. To create a composite image of the core at a single axial 
depth, the microscope stage was scanned in a grid pattern (maximum area: 12.2 x 12.2 mm2); 
composite images of cores were typically 4 x 12.2 mm2. After imaging, the cores were stored in 
PBS and submitted to the IBC tissue registry for processing, including standard histologic 
preparation, fixation, and staining with hematoxylin and eosin (H&E).  
62 
 
Grayscale fluorescence images of cores were acquired with the confocal microscope. The 
grayscale confocal fluorescence images were false colored to resemble histologic staining by 
combining the experimentally-determined color values for hematoxylin and eosin reported by 
Gareau [139] into a single set of color values: H = [1.3 0.75 1.88], where [red (k=1) green (k=2) 
and blue (k=3)]. False color was applied to each pixel of confocal images (C) as follows:  
𝐶𝑥,𝑦,𝑘 = 1 − 𝐹𝑥,𝑦(2 − 𝐻𝑘) 
where F is the grayscale confocal fluorescence image with each pixel normalized to the 
maximum [139]. The individual grayscale confocal images were automatically stitched together 
immediately following acquisition by the confocal microscope to form a composite grayscale 
image of each core. False colored confocal images were manually stitched together, using the 
grayscale confocal image as a guide, to form a composite false colored image of each core.  
A board-certified, dedicated breast pathologist (author S. Krishnamurthy) assessed H&E-
stained slides with a 10X objective lens and evaluated confocal images at comparable 
magnification. Invasive tumor cellularity was estimated in three images for each core: one 
histologic image prepared with standard fixation in neutral buffered formalin, routinely 
processed, embedded in paraffin followed by H&E staining, one composite grayscale confocal 
image, and one false colored confocal image - using standard histologic criteria [15]. Tumor 
cellularity was defined as the percentage of the core comprised of invasive breast carcinoma 
[140].  
A kappa coefficient was calculated for each combination of confocal and histologic 
image types (histologic vs. grayscale confocal images and histologic vs. false colored confocal 
images), in order to compare the agreement between invasive tumor cellularity estimated from 
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histologic, grayscale confocal, and false colored confocal images. In this calculation of inter-
rater agreement, each image type was considered to be one “rater”.  
4.3  Results 
A total of 23 cores were collected from 23 patients with untreated, clinically suspected IBC 
[123] (Table 4-1). Twenty of the cores contained neoplastic tissue, identified by standard 
histologic criteria in histologic images. The average time to acquire a composite confocal image 
was 1 minute, 54 seconds (Table 4-1). False coloring produced confocal images that visually 
resembled tissue sections stained with hematoxylin and eosin. 
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Table 4-1: Percent invasive tumor cellularity in IBC cores estimated in histologic, grayscale confocal, and false colored 
confocal images. Histologic slides were stained with hematoxylin and eosin (H&E). Imaging time indicates the time to 
acquire a composite grayscale confocal image. The average imaging time was 01:54 mm:ss.  
Adequacy 
for Tumor 
Diagnosis 
Core 
# 
Estimated Invasive Tumor Cellularity in 
Images of Core Needle Biopsy Specimens 
Imaging 
Time 
(MM:SS) 
Histologic IBC type Tumor grade 
  
Histology 
(H&E) 
Confocal 
(Grayscale) 
Confocal 
(False 
Coloring) 
   
Adequate 
1 90% 75-80% 80% 00:53 Invasive ductal carcinoma 2 
2 5% 5% 5% 00:53 Invasive ductal carcinoma with mucinous carcinoma 3 
3 10% 25% 20% 02:41 Invasive ductal carcinoma 3 
4 20% 5% 20% 01:47 Invasive ductal carcinoma 2 
5 75% 75% 20% 02:51 Invasive ductal carcinoma 3 
6 25% 20% 20% 02:07 Invasive ductal carcinoma 3 
7 20% 20% 20% 02:54 Invasive ductal carcinoma 3 
8 100% 100% 30% 02:51 Invasive ductal carcinoma 3 
9 5% 5-10% 5% 02:51 Invasive ductal carcinoma 3 
10 25-30% 25% 40% 01:46 Invasive ductal carcinoma 2 
11 95% 80-95% 90% 02:33 Invasive ductal carcinoma 3 
12 30% 30% 30% 02:09 Invasive ductal carcinoma 3 
13 30% 20% 50% 01:01 Invasive ductal carcinoma 3 
14 95% 70% 90% 01:04 Invasive ductal carcinoma 3 
15 80% 75% 90% 01:04 
Invasive ductal carcinoma 
with micropapillary 
features 
2 
16 70% 90-95% 95% 01:04 Invasive ductal carcinoma 3 
17 20% 10% 10% 01:04 Invasive ductal and lobular carcinoma 1 
18 50% 10-15% 15% 02:51 Invasive lobular carcinoma 3 
19 25% 30% 25% 01:47 Invasive ductal carcinoma 2 
20 30-40% 40% 20% 01:25 Invasive ductal carcinoma 3 
Inadequate 
21 0% 0% 5% 02:51 Invasive ductal carcinoma 3 
22 0% 0% 0% 01:04 Invasive ductal carcinoma 3 
23 0% 0% 0% 01:47 Invasive ductal carcinoma 2 
 
Representative histologic, grayscale confocal, and false colored confocal images of cores 
that contain IBC tissue are shown in Figure 4-1 and Figure 4-2. Figure 4-1 shows a core that 
contains both neoplastic and non-neoplastic tissue, with an estimated 25% cellularity in the 
histologic image; cellularity was estimated as 30% and 25% in grayscale confocal and false 
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colored confocal images, respectively. Figure 4-2 shows a core with 80% cellularity estimated in 
the histologic image, 75% cellularity estimated in the grayscale confocal image, and 90% 
cellularity estimated in the false colored confocal image.  
 
Figure 4-1: Representative core with invasive tumor and non-neoplastic tissue (core 19); 25% cellularity estimated by 
author S.K. in histologic image (standard H&E staining), 30% cellularity estimated in grayscale confocal fluorescence 
image (0.01% proflavine staining), 25% cellularity estimated in false colored confocal fluorescence image derived from 
grayscale image (0.01% proflavine staining). The solid outlined region indicates areas of the CNB specimen that contain 
invasive tumor. The scale bar at left is 750 μm. The insets at right show the border between neoplastic and non-neoplastic 
tissue in the CNB specimen. The locations of the insets are indicated in each core by a square with dashed lines. The scale 
bar at right is 100 μm. 
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Figure 4-2: Representative core with invasive tumor (core 15); 80% cellularity estimated by author S.K. in histologic 
image (standard H&E staining), 75% cellularity estimated in grayscale confocal fluorescence image (0.01% proflavine 
staining), 90% cellularity estimated in false colored confocal fluorescence image derived from grayscale image (0.01% 
proflavine staining). The solid outlined region indicates areas of the CNB specimen that contain neoplastic tissue. The 
scale bar at left is 750 μm. The insets at right show a region of neoplastic tissue in the CNB specimen. The locations of the 
insets are indicated in each core by a square with dashed lines. The scale bar at right is 100 μm.  
 
 Three cores acquired from patients diagnosed with IBC were considered to be 
inadequate as a result of sampling error; the histologic image contained no neoplastic tissue 
despite a clinical diagnosis of IBC. Representative images of an inadequate core consisting of 
adipose tissue and no neoplastic tissue, based on assessment of the histologic image, are shown 
in Figure 4-3. All three images of the core estimated cellularity as 0%.  
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Figure 4-3: Representative core with no invasive tumor (core 22); 0% cellularity estimated by author S.K. in histologic 
image (standard H&E staining), 0% cellularity estimated in grayscale confocal fluorescence image (0.01% proflavine 
staining), 0% cellularity estimated in false colored confocal fluorescence image derived from grayscale image (0.01% 
proflavine staining). This core is considered inadequate due to sampling error; no invasive tumor is visible despite a 
clinical indication of IBC. The scale bar at left is 750 μm. The insets at right show a region of non-neoplastic tissue in the 
CNB specimen. The locations of the insets are indicated in each core by a square with dashed lines. The scale bar at right 
is 100 μm. 
 
Estimates of tumor cellularity based on histologic, grayscale confocal, and false colored 
confocal images for all specimens are summarized in Error! Reference source not found.. 
Figure 4-4 illustrates the agreement between tumor cellularity estimated in histologic and 
grayscale confocal images (Figure 4-4A) and in histologic and false colored confocal images 
(Figure 4-4B). Each data point represents a core needle biopsy specimen from which tumor 
cellularity was estimated. Dashed lines indicate the linear fit for each set of data points and 
Pearson coefficient (R2) values quantify the linear fit of the data. Tumor cellularity estimates 
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were more consistent between histologic and grayscale confocal images (R2 = 0.88) than between 
histologic and false colored confocal images (R2 = 0.61).  
 
Figure 4-4: Scatterplots illustrating agreement on estimated invasive tumor cellularity between image types. Each data 
point represents a CNB specimen. Dashed lines represent the linear fit of the data. Pearson coefficients (R²) quantify the 
linear fit of invasive tumor cellularity data. A: Invasive tumor cellularity estimates from grayscale confocal images and 
histologic images. B: Invasive tumor cellularity estimates from false colored confocal images and histologic images.  
 
A kappa coefficient was calculated [125, 141] to quantify the agreement between 
histologic images and either grayscale or false colored images. Standard error and p values for 
kappa were also quantified (Table 4-2). The kappa value calculated for agreement between 
histologic and grayscale confocal images indicate moderate agreement based on defined 
categories for kappa values [126, 141]; κ = 0.48 ± 0.09 (p < 0.001). Agreement between 
histologic and false colored confocal images was fair and not statistically significant; κ = 0.28 ± 
0.26 (p = 0.14).  
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Table 4-2: Inter-rater agreement of estimated invasive tumor cellularity between the types of images, quantified by the 
kappa coefficient and standard error [125]. Level of agreement is based on categories described by Viera and Garrett 
[141]. P value was calculated using a normal distribution. 
Interrater Agreement – Two Techniques 
Image types 
Kappa 
Coefficient 
Standard 
Error 
Level of 
Agreement 
P value 
Histologic vs. 
Grayscale Confocal 
0.477 0.088 Moderate 3.43E-08 
Histologic vs. 
False Colored Confocal 
0.280 0.258 Fair 0.139 
 
4.4  Discussion 
The objective of this work was to determine the feasibility of using confocal fluorescence 
microscopy for immediate assessment of invasive tumor cellularity of CNBs in patients with 
IBC. Composite grayscale confocal images of CNB specimens were acquired in an average time 
of 2 minutes. Statistical analysis shows that there is moderate agreement between tumor 
cellularity estimated from histologic images and grayscale confocal images. False coloring the 
confocal images using a single analog for histologic staining does not improve agreement. These 
findings demonstrate that confocal fluorescence microscopy could be used to assess adequacy of 
IBC CNB specimens. This technique may be useful to ensure procurement of high quality CNBs 
not only for routine histopathological diagnosis but also for ancillary studies including 
immunohistochemistry and molecular testing. 
Of the 3 CNB specimens that were determined to be inadequate by histologic assessment, 
one had benign lobules and fibrous tissue (core #21) and two consisted completely of adipose 
tissue (cores #22, 23). These cores were identified as inadequate based on tumor cellularity 
estimated as 0-5% in histologic, grayscale confocal, and false colored confocal images (Table 
4-1). Of the 20 CNB specimens that were determined to be adequate by histologic assessment, 20 
were diagnosed as invasive carcinoma; morphological features of invasive carcinoma were also 
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recognized in grayscale confocal and false colored confocal images. One CNB specimen was 
diagnosed as mucinous carcinoma (core #2) based on standard histologic criteria [15] and was 
also recognized as such on the confocal images. 
IBC is an aggressive type of breast cancer, which is known to metastasize through the 
lymphatic system and typically presents as a non-palpable lesion [123, 131, 132]. To obtain a 
rapid and accurate diagnosis of IBC, there must be a reliable method to sample tissue. Although 
inter-rater agreement is typically high for histologic diagnosis [142-145], the rate of inadequate 
samples is a limitation of CNB as a sampling technique for breast cancer diagnosis [135, 136, 
142, 143, 146]. Shah and colleagues showed that the rate of sampling error leading to inadequate 
CNB specimens can be as high as 9.1% [135]. Therefore, there is a need for a technique that can 
evaluate specimen adequacy [135] with a relatively high sensitivity and specificity.  
Previous studies have illustrated the feasibility of evaluating breast tissue specimens with 
confocal microscopy [1, 96, 120, 121, 137]. Schiffhauer and colleagues evaluated confocal 
reflectance microscopy for screening unfixed breast CNB specimens with a range of neoplastic 
and non-neoplastic histologic features. Their study showed that there were adequate morphologic 
and cellular features in confocal reflectance images to allow correlation to histologic images 
[121]. In this study, we chose to focus on inflammatory breast cancer, because we wanted to 
determine if assessment of confocal fluorescence microscopy images of fresh cores would show 
which cores had insufficient tumor tissue for diagnosis and therefore identify cases for which a 
repeat biopsy was needed. Our previous work showed that confocal fluorescence microscopy 
images provide sufficient detail to distinguish between neoplastic such as ductal carcinoma in 
situ and invasive ductal and lobular carcinoma and non-neoplastic breast features, including 
benign ducts, lobules, and hyperplasia [1]. We characterized inter-rater agreement between 
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pathologists who assessed confocal fluorescence with a kappa coefficient for multiple ratings per 
subject. The kappa coefficient described in our previous work (0.51, p < 0.001) between 
pathologists assessing confocal images indicated moderate agreement based on defined 
categories of kappa coefficients  [126, 141]. This level of agreement is similar to the moderate 
agreement between a single rater’s assessment of grayscale confocal and histologic images 
shown in Table 4-2 (0.477, p < 0.001). The findings of these two studies suggest that confocal 
fluorescence images could potentially be used to assess adequacy of breast core needle biopsies 
with many histologic features. 
False coloring to mimic histologic staining in confocal images of breast tissue has been 
demonstrated in two studies [139, 147]. Gareau showed that the false coloring technique using 
confocal reflectance and fluorescence microscopy to mimic hematoxylin and eosin staining, 
respectively, produced multimodal confocal images mimicking the appearance of corresponding 
histologic images [139]. Bini and colleagues used false coloring for tissue obtained from Mohs 
skin excisions and demonstrated correlation between confocal mosaics and histologic images 
[147]. Previous studies showed that false coloring improved correlation between confocal and 
histologic images [126, 141]. However, in contrast to the previous studies which used both 
reflectance and fluorescence images to mimic hematoxylin and eosin staining, we used only 
fluorescence images to mimic histologic staining of the tissue section. It was not possible to use 
multimodal confocal images because reflectance images were not collected for every CNB 
specimen, and because some confocal reflectance images were not aligned laterally or axially 
with the confocal fluorescence images of the corresponding core needle biopsy specimen.  
In conclusion, we present the results of a proof of concept study comparing estimated 
invasive tumor cellularity between grayscale confocal, false colored confocal, and histologic 
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images of 23 IBC CNB specimens. Grayscale confocal images require an average of only 2 
minutes for acquisition and allow immediate evaluation of invasive tumor cellularity in IBC 
CNB specimens; agreement with histologic images is moderate. We show that confocal 
fluorescence microscopy could be used for immediate assessment of CNB specimen adequacy, 
so that additional biopsies for diagnosis, bio-banking, or genetic sequencing studies can be 
performed on site without need for a repeat visit. Additional larger prospective studies are 
warranted to validate our findings for the potential utilization of confocal fluorescence 
microscopy in routine pathology practice as a robust technique for immediate assessment of 
specimen adequacy of IBC CNBs. 
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5 CHAPTER 5: Confocal fluorescence microscopy compared to 
histologic slides for breast cancer diagnosis and grading 
 
ABSTRACT: Histologic assessment is the current standard for diagnosis of breast cancer.  
Optical imaging techniques are evolving which allow rapid examination of tissues without 
extensive preparation or loss of tissue. We performed a preliminary study to evaluate the 
potential of assigning diagnosis and grade to images of breast tumors acquired with confocal 
fluorescence microscopy. A total of 30 breast tissue specimens were acquired from 30 patients, 
stained with proflavine and imaged with a confocal fluorescence microscope. The tissues were 
then fixed in formalin and routinely processed to generate tissue sections, which were stained 
with hematoxylin and eosin. An expert pathologist performed two reviews of all confocal and 
histologic images and assigned a diagnosis and grade to each. Overall, 29 of 30 specimens were 
correctly classified as neoplasia in confocal images. Diagnosis and grade assigned to confocal 
and histologic images agreed for 24/30 specimens and 21/30 specimens, respectively. The kappa 
coefficient to characterize agreement between two reviews of histologic images was perfect for 
assignment of diagnosis (κ = 1.00 ± 0.15) and substantial for tumor grade (κ = 0.75 ± 0.18). 
Agreement between two reviews of confocal images was fair for assignment of both diagnosis 
and grade (κ = 0.36 ± 0.14 and κ = 0.30 ± 0.15, respectively). These findings indicate that 
confocal microscopy has potential as a technique for rapid diagnosis of breast tissue, but 
improved lateral resolution and additional contrast agents targeting markers associated with 
tumor type and grade may be needed to improve breast cancer diagnosis and grading.  
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5.1 Introduction 
The standard of care for the evaluation of breast tissues procured by image-guided 
biopsies or surgical excision is conventional cytopathological and histopathological examination. 
Immediate assessment of tissue procured by fine needle aspiration biopsy and core needle biopsy 
can be performed by cytopathological examination of aspirated smears [113, 133, 144, 148] or 
touch preparation of the needle cores [113, 134, 142, 144, 149-151]. While touch preparation can 
be used for immediate evaluation of core needle biopsies or larger tissue specimens acquired 
from surgical resections, the lack of availability of tissue architecture can lower the sensitivity 
and specificity of interpretation with this technique [133, 144].  The most commonly used 
procedure for the intraoperative assessment of tissues obtained by surgical resections in 
pathology laboratories is frozen section analysis [152-154].  Frozen section analysis entails 
embedding the tissue in a mounting medium such as optimal cutting medium to create frozen 
tissue blocks that are sectioned in a cryotome to generate 5 µm thick frozen tissue sections, 
which are fixed in alcohol, stained by hematoxylin and eosin (H&E), and immediately 
interpreted by a pathologist.  The technique of rapidly freezing, cutting and staining the tissue 
allows rapid evaluation of the tissue, but is associated with limitations, such as loss of tissue in 
the cryostat while preparing the tissue, introduction of freezing artifacts, and difficulty in cutting 
tissues that contain adipose tissue or bone [113, 155].    
In light of these limitations, several imaging techniques to rapidly assess breast tissue 
specimens are being investigated, including optical coherence tomography (OCT), 
radiofrequency spectroscopy, and high-frequency ultrasound [91, 93, 94, 156]. A recent study by 
Zysk et al. reported on the use of a handheld OCT probe to evaluate surgical margins following 
breast-conserving surgery. Their findings indicate that intraoperative assessment with OCT could 
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potentially reduce the rate of reoperations following breast-conserving surgery by identifying 
positive tumor margins at the point-of-care [94].   
Confocal microscopy is a high resolution optical imaging technique that has been 
evaluated in several studies for its potential role in rapid breast tissue assessment. A previous 
study demonstrated that confocal images of fresh, surgically excised breast tissue contain 
sufficient detail to identify neoplasia with comparable accuracy to histologic assessment [1]. 
Other studies assessed the potential of using confocal fluorescence microscopy to evaluate core 
needle biopsy specimens [121] and assess their adequacy based on estimated tumor cellularity 
[2]. However, previous studies have not shown whether images acquired with confocal 
microscopy contain sufficient detail to make a primary diagnosis of the tissue including 
categorization of the tissue as benign or malignant and for assessing the type and grade of 
malignant tumors. 
In this preliminary study, our objective was to compare the diagnosis of breast masses 
made using confocal fluorescence images with conventional histopathological examination of the 
same tissue. We investigated utilization of confocal fluorescence images for initial categorization 
of the breast mass as benign or malignant, subsequent classification of the latter category of 
tumors as carcinoma in situ or as invasive carcinoma, and grading of the tumors.  
5.2 Materials and Methods 
Human breast tissue specimens were acquired through a protocol approved by the 
institutional review boards at the University of Texas M.D. Anderson Cancer Center and Rice 
University. Patients were eligible to participate in the study if they provided informed consent 
and were undergoing primary surgical resection for the management of biopsy-proven breast 
cancer. Breast tissue specimens measuring approximately 15 x 15 x 8 mm were sampled from 
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the area of interest in the surgical specimen within 30 minutes of resection. Prior to imaging, all 
breast tissue specimens were stained with proflavine, a fluorescent contrast agent that stains cell 
nuclei in optical images [1, 102, 122], which was topically applied as a 0.01% solution in 1x 
phosphate-buffered saline (PBS) for 1 minute followed by a wash with 1x PBS. 
Confocal fluorescence images were acquired from all breast specimens using a scanning 
confocal microscope (Vivascope 2500®; Caliber Imaging and Diagnostics Inc., Rochester, New 
York) as described previously [2-4]. The proflavine-stained breast tissue specimen was 
positioned on the confocal microscope stage and imaged at 2.1 ± 0.4 mW at 488 nm laser 
excitation with a 550 ± 44 nm bandpass filter through a 30X water immersion lens (numerical 
aperture, N.A. = 0.8). At the center of each 750 x 750 µm  confocal field of view, the lateral 
resolution is 2.0 µm and axial resolution is 5.0 µm, as reported by the manufacturer. The 
microscope acquired images in a grid pattern and images were assembled into a 12.2 x 12.2 mm 
composite image. After image acquisition, breast tissue specimens were submitted for standard 
fixation in 10% neutral buffered formalin, processing, embedding in paraffin wax and cut to 
generate 5 µm tissue sections which were stained by hematoxylin and eosin (H&E).  
Composite confocal images and histologic slides were reviewed in random order by a 
board-certified breast pathologist (author S.K.) who was blinded to patient identification and the 
surgical pathology accession number. Histologic images of approximately 5 -10 µm thick tissue 
sections were reviewed on a light microscope (Olympus) at 10X (N.A. = 0.25), 20X (N.A. = 
0.40), and 40X (N.A. = 0.65), and evaluated using conventional histopathological criteria for 
categorization of the breast masses as benign or malignant. Malignant tumors were classified as 
carcinoma in situ or invasive carcinoma, which were further categorized as ductal or lobular in 
phenotype. Invasive tumors were graded based on the Nottingham histologic grading system as 
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low, intermediate and high [15]. Ductal carcinoma in situ was graded based on nuclear size as 
low, intermediate, or high grade.   
All confocal images were reviewed by viewing on a computer monitor at low 
magnification (5X) to view the entire specimen and at higher magnification (30X). The 
theoretical lateral resolution at the settings used for visualizing the confocal images, assuming a 
wavelength of 550 nm, was 1.1 µm, 0.7 µm, and 0.45 µm, respectively. Since confocal images 
have lower lateral resolution than standard histologic slides, it was not possible to identify some 
features commonly used to assign tumor grade in H&E sections, such as mitotic figures and 
presence of nucleoli, in confocal images. Thus, confocal images were visually assessed and 
invasive tumor was graded based on modified criteria taking into consideration nuclear size, 
nuclear pleomorphism and gland formation by the tumor cells comprising the invasive tumor [1]. 
Invasive tumors with gland formation in >75% of the tumor with low to intermediate sized 
nuclei were graded as low grade and those with absence of glands, large nuclear size with 
nuclear pleomorphism were graded as high grade. Tumors with features in between these 
characteristics were categorized as intermediate in grade.  
Each confocal and histologic image was reviewed twice, during separate sessions in 
which the reviewing pathologist assigned a diagnosis and tumor grade to each confocal and 
histologic image. Diagnoses assigned to specimens included ductal carcinoma in situ (DCIS), 
invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and “negative for tumor.” 
For the purposes of data analysis we categorized ductal carcinoma in situ and invasive tumors as 
either low and intermediate grade or high grade.  Diagnoses and grades assigned to confocal 
images were compared to those assigned during review of the corresponding histologic images.  
A kappa coefficient [125, 126, 141] was calculated to quantify the agreement between tumor 
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diagnosis and grade assigned in the first and second reviews of confocal images and histologic 
images. In this calculation, each review of either confocal or histologic images was considered to 
be one “rater.” Standard error was estimated for each kappa coefficient. The critical ratio, z, the 
ratio between each kappa coefficient and the estimated value of standard error, was calculated 
for each kappa coefficient. A p value was estimated by referring the critical ratio to tables of the 
standard normal distribution in order to test the hypothesis that each kappa coefficient was 
significantly larger than zero [125, 126].  
5.3 Results 
A total of 30 tissue specimens collected from breast tumor masses were imaged to obtain 
gray scale images using confocal fluorescence microscope after staining with proflavine. 
Hematoxylin and eosin stained tissue sections of the same tissue were available for conventional 
histopathologic examination.  
Figure 5-1 illustrates representative confocal and histologic images of breast tissue 
specimens, which were assigned the same diagnosis and grade in confocal images and on 
histologic examination. The top row (Figure 5-1: A-D) shows a lesion identified as 
low/intermediate grade DCIS in the corresponding histologic slide and confocal image based on 
the presence of ductal spaces filled with cells with enlarged nuclei, and no visible stromal 
invasion. The middle row (Figure 5-1: E-H) shows a lesion identified as low/intermediate grade 
IDC based on the presence of enlarged nuclei with moderate pleomorphism, disorganized 
proliferation invading into stromal tissue, and widespread gland formation. The bottom row 
(Figure 5-1: I-L) shows a lesion identified as high grade IDC based on the presence of clusters of 
cells with enlarged nuclei invading into stromal tissue with minimal gland formation and nuclear 
pleomorphism.  
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Figure 5-1: Representative confocal images and H&E-stained histologic slides of human breast tissue specimens assigned 
the same diagnosis and grade based on visual assessment. A-D: low/intermediate grade DCIS. E-H: low grade IDC. I-L: 
high grade IDC. Low magnification images show the lesion sections assessed. Yellow and black boxes on low 
magnification images indicate the areas shown in high magnification images. Scale bars represent 1.5 mm for low 
magnification images or 100 µm for high magnification images.  
 
Table 5-1: Results of tumor diagnosis based on visual assessment of confocal and histologic images 
   Confocal microscopy  
  Negative for tumor DCIS IDC ILC Total 
Histology 
Negative for tumor 0 0 0 0 0 
DCIS 1 3 2 0 6 
IDC 0 0 21 0 21 
 ILC 0 0 3 0 3 
 Total 1 3 26 0 30 
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Table 5-1 compares the results of tumor diagnosis made from the first reading of the 
histologic diagnosis to that of the first reading of confocal fluorescence microscopy. Of the 30 
specimens evaluated, 29 specimens were classified as neoplastic in both confocal and histologic 
images. Twenty-one of the specimens were diagnosed as IDC and three specimens were 
diagnosed as DCIS in both confocal and histologic images. All three specimens diagnosed as 
ILC in histologic images were misclassified as IDC in confocal images. Half of the DCIS 
specimens (3/6) diagnosed in histologic images were misclassified as IDC or negative for tumor 
in confocal images.  
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Figure 5-2: Representative confocal images and H&E-stained histologic slides of human breast tissue specimens assigned 
different diagnoses based on visual assessment. A,B: solid pattern ILC called IDC in confocal image. C,D: papillary 
pattern DCIS called IDC in confocal image. D: Arrows indicate folds of carcinoma cells characteristic of papillary pattern 
DCIS. E,F: cribriform pattern DCIS called negative for tumor in confocal image. F: Arrows indicate myoepithelial cells 
surrounding duct with DCIS. G,H: Histiocytes called IDC in confocal image. H: Arrows indicate benign histiocytes. Scale 
bars represent 100 µm for all images.  
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Figure 5-2 illustrates four specimens that were assigned incorrect diagnoses in confocal 
images. Each row illustrates a different cause of misdiagnosis in confocal images. In the top row 
(Figure 5-2: A,B) solid pattern ILC was misdiagnosed as IDC in the composite confocal image.  
The sheets of invasive tumor cells of solid pattern invasive lobular carcinoma invasion 
resembled IDC. Unlike the characteristic single-file invasion pattern of classic ILC, the solid 
pattern of ILC is a well-recognized cause of misdiagnosis even on conventional histopathological 
examination [157].  In the second row (Figure 5-2: C,D) DCIS with papillary pattern was 
misdiagnosed as IDC in the confocal image.  The fibrovascular cores in the lesion were not well 
recognized in the confocal images. The tumor cells surrounding the fibrovascular cores alone 
were highlighted in the confocal images resulting in misdiagnosis as invasive carcinoma 
(indicated by arrows in Figure 5-2 D). The third row (Figure 5-2: E,F) shows cribriform pattern 
DCIS diagnosed on H&E section that was interpreted  as negative for tumor on confocal images. 
Visual comparison of these images suggested that the histologic slide and the corresponding 
composite confocal image were acquired from different axial sections of this specimen, because 
the features of the lesion differed between the two images; in the confocal image the lesion  
showed inflammation and reactive changes adjacent to the previous biopsy site, while the 
histologic image showed several ductal spaces involved by DCIS. The bottom row (Figure 5-2: 
G,H) shows histiocytes (indicated by arrows in Figure 5-2 H) that were misdiagnosed as IDC in 
the confocal image. 
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Table 5-2: Summary of grades assigned in one review of confocal and histologic images 
  Confocal microscopy  
  Low / intermediate grade High grade 
Undetermined 
grade Total 
Histology 
Low / intermediate grade 19 1 1 21 
High grade 6 2 1 9 
Undetermined grade 0 0 0 0 
 Total 25 3 2 30 
 
illustrates four specimens that were assigned incorrect diagnoses in confocal images. Each 
row illustrates a different cause of misdiagnosis in confocal images. In the top row (Figure 5-2: 
A,B) solid pattern ILC was misdiagnosed as IDC in the composite confocal image.  The sheets of 
invasive tumor cells of solid pattern invasive lobular carcinoma invasion resembled IDC. Unlike 
the characteristic single-file invasion pattern of classic ILC, the solid pattern of ILC is a well-
recognized cause of misdiagnosis even on conventional histopathological examination [157].  In 
the second row (Figure 5-2: C,D) DCIS with papillary pattern was misdiagnosed as IDC in the 
confocal image.  The fibrovascular cores in the lesion were not well recognized in the confocal 
images. The tumor cells surrounding the fibrovascular cores alone were highlighted in the 
confocal images resulting in misdiagnosis as invasive carcinoma (indicated by arrows in Figure 
5-2 D). The third row (Figure 5-2: E,F) shows cribriform pattern DCIS diagnosed on H&E 
section that was interpreted  as negative for tumor on confocal images. Visual comparison of 
these images suggested that the histologic slide and the corresponding composite confocal image 
were acquired from different axial sections of this specimen, because the features of the lesion 
differed between the two images; in the confocal image the lesion  showed inflammation and 
reactive changes adjacent to the previous biopsy site, while the histologic image showed several 
ductal spaces involved by DCIS. The bottom row (Figure 5-2: G,H) shows histiocytes (indicated 
by arrows in Figure 5-2 H) that were misdiagnosed as IDC in the confocal image. 
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Table 5-2 illustrates the results of tumor grade classification in the first review of images 
acquired by histology with H&E staining and confocal fluorescence microscopy. Of the 30 
specimens evaluated, 19 specimens were classified as “low/intermediate grade” and two 
specimens were classified as “high grade” in both confocal and histologic images. Six specimens 
that were identified as high grade in histologic images were misclassified as low/intermediate 
grade in confocal images, and one specimen identified as low/intermediate grade in the 
histologic image was classified as high grade in the corresponding confocal image. Two 
specimens, one classified as low/intermediate grade and one classified as high grade in histologic 
images, could not be classified as either high or low/intermediate grade in confocal images, 
because poor contrast and resolution precluded interpretation. 
85 
 
 
Figure 5-3: Representative confocal images and H&E-stained histologic slides of human breast tissue specimens assigned 
different grades based on visual assessment. A-D: High grade IDC called low/intermediate grade IDC in confocal images. 
A, C: Square regions indicated by white dashed line indicate areas shown at higher magnification in B and D. D: 
Carcinoma cells with marked nuclear pleomorphism are indicated by arrows and areas with lymphocytic infiltration are 
indicated by asterisks. E-H: Low/intermediate grade IDC called high grade IDC in confocal images. E, G: Square regions 
indicated by white dashed line indicate areas shown at higher magnification in F and H. H: Carcinoma cells with 
prominent nucleoli are indicated by arrows. Scale bars represent 100 µm for A, C, E, and G, and 50 µm for B, D, E, and 
H.   
 
Figure 5-3 illustrates two specimens that were assigned different grades based on visual 
assessment of corresponding histologic and confocal images. The top row (Figure 5-3: A-D) 
shows high grade IDC that was misclassified as low/intermediate grade, because the presence of 
inflammation indicated by infiltrating lymphocytes (indicated by asterisks in Figure 5-3 D) 
resembled low grade disease and carcinoma cells with marked nuclear pleomorphism (indicated 
by arrows in Figure 5-3 D) were not well-recognized in the confocal image. The bottom row 
(Figure 5-3: E-H) shows low/intermediate grade IDC that was misclassified as high grade in the 
confocal image. Very focal areas showed larger nuclei which were misinterpreted as high grade 
for the overall tumor grade which comprised of sheets of tumor cells without gland formation but 
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with intermediate sized tumor nuclei. The carcinoma cells with prominent nucleoli in a focal area 
of the tumor are shown in the histologic image (indicated by arrows in Figure 5-3 H). The 
corresponding area in the confocal image that led to the misinterpretation is shown in Figure 5-3. 
Table 5-3: Kappa coefficient characterizing agreement between two reviews of diagnosis and grade for each set of 
histologic and confocal images 
Evaluation Image Types Kappa Coefficient 
Standard 
Error 
Level of 
Agreement  
Critical 
Ratio p value 
Diagnosis 
Histology review 1 versus 
histology review 2 1.00 0.15 Perfect 6.7 
8.5E-
12 
Confocal review 1 versus 
confocal review 2 0.36 0.14 Fair 2.5 0.01 
Tumor 
Grade 
Histology review 1 versus 
histology review 2 0.75 0.18 Substantial 4.1 
1.8E-
05 
Confocal review 1 versus 
confocal review 2 0.30 0.15 Fair 2.0 0.02 
 
A kappa coefficient was calculated [125, 126] to quantify the agreement between two 
reviews of diagnosis and grade assigned to breast specimens in histologic and confocal images. 
There was perfect agreement between assigned diagnoses and substantial agreement between 
assigned grades in the two reviews of histologic images. Two reviews assessing diagnosis and 
grade in confocal images showed only fair agreement based on defined categories for kappa 
values [126, 141].  The estimated p values show that all kappa coefficients are significantly 
larger than zero, which indicates that each kappa coefficient represents higher agreement than 
would occur by chance.   
5.4 Discussion 
The objective of this study was to evaluate the feasibility of assessing tumor type and 
grade in images of neoplastic breast tissue specimens acquired with confocal fluorescence 
microscopy. A total of 29 out of 30 specimens (97%) were correctly classified as neoplasia based 
on assessment of confocal images. Reactive changes at previous biopsy site without any residual 
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tumor but including abundant histiocytes which was not correctly recognized on confocal 
fluorescence images accounted for the discordance and lowered sensitivity. Based on review of 
confocal and histologic images, 24 of 30 specimens (80%) were assigned the same diagnosis of 
tumor type and 21 of 30 specimens (70%) were assigned the same tumor grade. The agreement 
between tumor type and tumor grade assigned in two reviews of histologic images was perfect 
and substantial, respectively, based on calculated values of kappa coefficient [141]. However, the 
agreement between tumor type and tumor grade assigned in two reviews of confocal images was 
only fair.  
Several previous studies have evaluated the feasibility of visual assessment of confocal 
microscopy for rapid analysis of core needle biopsy specimens and surgical margins. Schiffhauer 
et al., Tilli et al., and Parrish et al. demonstrated the feasibility of using reflectance confocal 
microscopy to evaluate neoplasia in human breast and murine mammary tissue specimens in 
comparison to histologic assessment, but these studies did not classify specimens shown in 
confocal images by tumor type or grade [96, 120, 121]. We previously demonstrated the 
feasibility of visual assessment of confocal fluorescence images to distinguish between 
neoplastic and non-neoplastic breast tissue with comparable sensitivity and specificity to 
histologic assessment [1]. Here we performed a preliminary evaluation to investigate if confocal 
images contain sufficient detail to determine tumor type and grade following the initial 
categorization of the tumor as benign or malignant in nature. The results of this study show that 
the accuracy of tumor type and grade determined from confocal images (80% and 70%, 
respectively) is lower than the accuracy of simply identifying whether tissue is neoplastic or not 
(over 90%).  
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The major limitation of confocal microscopy platform used in the study was the poor 
lateral resolution compared to conventional light microscopic histopathological examination, 
which precludes optimal visualization of cytologic and architectural details leading to 
misclassification of tumor type and grade. The theoretical resolution of the light microscope with 
the 40X objective is 0.45 µm, while the lateral resolution of the confocal fluorescence 
microscope is 2.0 μm (30X objective). All 3 cases of ILC and 2 cases of DCIS were 
misclassified as IDC, because the small, round cells in ILC tumors (Figure 5-2B), the 
characteristic folds of papillary pattern DCIS (indicated by arrows in Figure 5-2D), and 
myoepithelial cells that surround cribriform pattern DCIS (indicated by arrows in Figure 5-2F) 
were not visible in confocal images. Poor lateral resolution in confocal images also limited 
recognition of characteristic features of different tumor grades, including nucleoli, nuclear 
pleomorphism, and lymphocytic infiltration (indicated by arrows in Figure 5-3 D and H, and 
asterisks in Figure 5-3 D, respectively). In addition, as shown in Figure 5-2 G and H, low 
resolution can cause some benign cells, such as infiltration of histiocytes, to be misclassified as 
neoplasia. Improvements in the confocal microscope are needed to improve the lateral resolution, 
which could improve the concordance of the diagnosis, typing, and grading of the breast tumors 
made using confocal fluorescence microscopy with conventional histopathologic examination. 
Future studies will provide valuable information regarding the extent of improvement of 
sensitivity and specificity of making a primary diagnosis using confocal fluorescence images. 
Classification of tumor type and grade in confocal fluorescence images could potentially 
also be improved by staining tissue specimens with additional fluorescent dyes conjugated to 
antibodies targeting markers [158, 159]. A variety of potential biomarkers could be targeted; for 
example, the loss of E-cadherin is commonly used to recognize lobular neoplasia by 
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immunohistochemistry [160-162]. E-cadherin is a transmembrane protein that mediates 
intercellular adhesion and is highly expressed in DCIS and IDC [163], but is poorly expressed in 
ILC [160, 162]. A previous study demonstrated staining MCF-7 breast cancer cells in vitro by 
conjugation of an anti-E-cadherin antibody (ab15148; Abcam®) to Alexa  555 Goat anti-rabbit 
(Invitrogen) [164]; this technique could potentially be optimized to target E-cadherin in intact 
tissue specimens. Similarly, calponin is a contractile protein that is expressed in contractile and 
cytoskeletal areas in smooth muscle cells, including in benign myoepithelial cells surrounding 
breast ducts [165, 166] and could be targeted to improve recognition of DCIS based on the 
presence of peripheral myoepithelial cells. P-cadherin is a transmembrane protein that mediates 
intercellular adhesion and is differentially expressed in high grade DCIS and low grade DCIS as 
well as high grade IDC and low grade IDC [159, 167, 168].  
Another potential source of error occurs when the optical section imaged by confocal 
microscopy is axially separated from the section of tissue prepared as a histologic slide, which 
likely occurred in the case shown in Figure 5-2 E,F. In this case, the architecture between the two 
sections of the same specimen differed such that DCIS was interpreted negative for tumor in the 
confocal image. However, this source of error would be difficult to overcome in future studies, 
since it is not always feasible to prepare histologic slides from sections within 20 µm of the 
surface, the approximate location of confocal image acquisition.  
Finally, in this study only one reader reviewed the confocal and histologic images. Future 
studies are needed to measure inter-observer agreement for assignment of diagnosis and grade to 
confocal and histologic images of breast neoplasia. 
90 
 
 In conclusion, this preliminary study evaluated the feasibility of making a primary 
histologic diagnosis and assigning a type and grade to malignant breast tissue specimens in 
confocal images. All 21 cases of IDC and 19 of 21 cases with low / intermediate grade tumor 
were accurately classified in confocal images. Ultimately, the findings of this study show that 
poor lateral resolution of the confocal microscopy platform used in our study limits 
differentiation of ILC and DCIS from IDC and classification of high grade lesions. Improved 
lateral resolution in the confocal microscope is needed to improve recognition of features that 
indicate tumor grade, such as nucleoli, nuclear pleomorphism, and lymphocytic infiltration. 
Fluorescent contrast agents targeting markers associated with tumor type and grade could also 
potentially be developed to improve classification of tumor type in confocal images.  
 
 
  
91 
 
6 CHAPTER 6: Micro-anatomical quantitative optical imaging: 
automated assessment of breast tissues using nuclear and ductal 
parameters3 
 
ABSTRACT: Pathologists currently diagnose breast lesions through histologic assessment, 
which requires fixation and tissue preparation. The diagnostic criteria used to classify breast 
lesions are qualitative and subjective, and inter-observer discordance has been shown to be a 
significant challenge in the diagnosis of selected breast lesions, particularly for borderline 
proliferative lesions. Thus, there is an opportunity to develop tools to rapidly visualize and 
quantitatively interpret breast tissue morphology for a variety of clinical applications. Toward 
this end, we acquired images of freshly excised breast tissue specimens using confocal 
fluorescence microscopy and proflavine as a topical stain. We developed computerized 
algorithms to segment and quantify nuclear and ductal parameters that characterize breast 
architectural features. A total of 33 parameters were evaluated and used as input to develop a 
decision tree model to classify benign and malignant breast tissue. The decision tree model that 
achieved the highest accuracy for distinguishing between benign and malignant breast features 
used the following parameters: standard deviation of inter-nuclear distance and number of duct 
lumens. The model achieved 81% sensitivity and 93% specificity, corresponding to an area 
under the curve of 0.93 and an overall accuracy of 90%. The model classified IDC and DCIS 
with 92% and 96% accuracy, respectively. The cross-validated model achieved 75% sensitivity 
and 93% specificity and an overall accuracy of 88%. These results suggest that proflavine 
                                                          
3 The contents of this chapter have been published with no changes in the following journal article: Dobbs JL, 
Mueller JL, Krishnamurthy S, Shin D, Kuerer H, Yang W, Richards-Kortum R. Micro-anatomical quantitative 
optical imaging: towards automated assessment of breast tissues. Breast Cancer Res 2015; 17(105) DOI 
10.1186/s13058-015-0617-9. This article is distributed under the terms of the Creative Commons Attribution 4.0 
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and 
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were made. 
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staining and confocal fluorescence microscopy combined with image analysis strategies to 
segment morphological features could potentially be used to quantitatively diagnose freshly 
obtained breast tissue at the point of care without the need for tissue preparation.  
 
6.1  Introduction 
Breast cancer diagnosis is an intricate process, which requires tissue procurement, rigorous 
tissue preparation and histologic assessment whether it is in the context of core needle biopsy 
diagnosis or surgical excision. Fixed tissue samples are processed after harvesting and are 
evaluated for presence and type of malignant breast tissue based on standardized histologic 
criteria [15, 79, 80, 169], which employ cytological and qualitative architectural features. Breast 
tumors that are diagnosed as malignant in nature are graded using different types of grading 
systems to categorize the tumors into groups to reflect their biology of progression. One of the 
most widely-used grading systems was developed by Bloom and Richardson in 1957, which used 
only qualitative criteria to evaluate breast lesions [169]. In 1991, Elston and Ellis published the 
Nottigham modification to the Bloom and Richardson grading system, which incorporated semi-
quantitative criteria to evaluate tubule formation, nuclear pleomorphism, and mitotic count [80].  
Extensive research has been done to evaluate the rate of inter- and intra-observer discordance 
using these grading systems for histologic assessment of fixed breast tissue. While some studies 
have shown that inter-observer agreement is high in the majority of cases [81], other studies have 
shown that subjective criteria can lead to inter-observer variation for margin assessment and poor 
reproducibility in evaluation of borderline and in situ lesions [82-87]. The availability of 
techniques that use quantitative criteria that can be applied without subjecting the tissue to 
processing can overcome the subjectivity of interpretation and may reduce the inter- and intra-
observer variability in the histological evaluation of breast tissue [170].  Such techniques could 
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also be potentially useful in settings lacking the human resources and equipment necessary to 
perform standard histologic assessment, which can be a challenge in many parts of the world 
[130].  
In order to characterize quantitative criteria to classify breast architecture, several studies 
have described segmentation algorithms based on nuclear [171-175] and ductal [176-178] 
morphometry in images of fixed tissue stained with hematoxylin and eosin (H&E) staining. 
Additionally, some recent studies evaluated nuclear morphometric parameters using wide-field 
fluorescence microscopy [179] and micro-optical computed tomography [180] to acquire images 
of breast tissue. Specifically, wide field fluorescence microscopy combined with watershed 
segmentation to quantify nuclei found that area fraction could distinguish between tumor and 
normal regions in excised rat mammary tissue with 97% accuracy [179]. Micro-optical computed 
tomography and nuclear morphometry was used to compare variations between human breast 
cell lines and found that nuclear volumes increased from normal to metastatic breast cells and 
that nuclei of abnormal cells contained more nucleoli [180].  
The idea of establishing quantitative criteria on fixed tissue can be taken one step further 
to be applied directly to intact specimens using other imaging modalities, which can obviate the 
need for extensive tissue processing. Several studies have already described the feasibility of 
imaging breast tissue with confocal microscopy in a clinical setting [1, 2, 96, 120, 121, 137]. 
Schiffhauer and colleagues showed that confocal reflectance microscopy could be used to image 
benign and malignant breast features and provide visual similarity to H&E micrographs [121].  
Abeytunge and colleagues demonstrated that confocal fluorescence microscopy can be used to 
rapidly acquire images of fresh tissue specimens between 1-2.5 cm2 in size [137]. Our group 
recently showed that confocal fluorescence microscopy yields images with sufficient detail to 
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identify benign and malignant breast architecture in freshly-excised tissue [1]. In another recent 
study, we demonstrated that confocal fluorescence images can be used to estimate percent tumor 
cellularity in core needle biopsy specimens and can indicate the adequacy of procured tissue for 
diagnosis and ancillary molecular and immunophnenotypic studies [2].  
The goal of this work is to combine both quantitative image processing techniques with 
optical microscopy of intact breast tissue specimens for interpretation of breast tissue at the point 
of care.  The benefits of this approach are minimal tissue processing, rapid diagnosis, and 
quantitative criteria that could potentially reduce the subjectivity with intra- and inter-observer 
variation in the evaluation of breast histology. In this study, we combine clinical confocal 
microscopy with a computerized image processing algorithm to quantify both nuclear and ductal 
morphology of breast tissue; we develop an algorithm using these parameters to classify breast 
tissue as benign - negative for tumor - or malignant - tumor tissue present. Although previous 
studies have described evaluation of breast architecture in histologic images [171-178], these 
studies only considered either nuclear or ductal parameters. We show that combining both yields 
improved diagnostic performance, particularly in the diagnosis of invasive ductal cancer (IDC) 
and ductal carcinoma in situ (DCIS). The nuclear and ductal parameters described in this study 
could potentially be used for objective categorization of breast lesions. 
 
6.2  Methods 
6.2.1 Breast tissue acquisition and preparation 
Fresh human breast tissue specimens were acquired through a protocol approved by The 
University of Texas MD Anderson Cancer Center and Rice University Institutional Review 
Boards, and each participant gave written informed consent. Fresh breast tissue was acquired 
from patients undergoing surgery to excise a clinically abnormal lesion. The procedure for tissue 
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preparation has been described previously [1]. In brief, two tissue specimens - one grossly 
abnormal and one grossly normal in appearance were acquired from each patient for image 
acquisition and evaluation; each specimen measured approximately 15 x 15 mm2 in size, with 
thickness varying from 2-7 mm. Within 30 minutes of surgical excision, breast tissue specimens 
were stained for one minute in a solution of 0.01% proflavine in 1X phosphate buffed saline 
(PBS). Proflavine is a nuclear contrast agent [122, 124], which has been used to stain breast 
tissue, oral mucosa, Barrett’s esophagus, cervical tissue, and sarcoma in previous studies [1, 2, 
102, 181-185]. Following topical application of proflavine, specimens were washed with 1X 
PBS and then immediately imaged.  
6.2.2 Image acquisition and evaluation 
Confocal fluorescence images were acquired from multiple sites within each specimen 
using a multi-wavelength scanning confocal microscope (Vivascope 2500®, Caliber Imaging and 
Diagnostics) as described previously [1, 2, 186]. Following topical application of proflavine and 
the PBS wash, each tissue specimen was positioned on the microscope stage and imaged using 
2.1 ± 0.4 mW power at 488 nm laser excitation, and the fluorescence was detected in a band pass 
of 550 ± 44 nm with a 30x water immersion lens.  At these settings, the lateral and axial 
resolution was 1.0 μm and 5.0 μm, respectively, in the center of the 750 x 750 μm2 field of view. 
A 12 x 12 mm2  composite image was created for both sides of each tissue specimen. To create 
the composite image, images were acquired from contiguous sites in a grid pattern (maximum 
area 12.2 x 12.2 mm2 ) over the surface of the specimen at an approximate depth of 20 μm. 
Following image acquisition, specimens were kept moist in 1X PBS and were submitted for 
routine histologic preparation and fixation. Samples were stained with H&E and fixed on 
microscope slides for histologic assessment.  
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A board-certified, breast pathologist (author S. Krishnamurthy) viewed composite 
confocal images and fixed tissue specimens stained with H&E using a conventional light 
microscope to identify sites that corresponded to the same approximate location in the specimen 
based on similar image morphology. Specifically we selected in-focus confocal microscope 
fields of view that contain representative examples of characteristic benign and malignant breast 
features.  Thus, at each site, a corresponding pair of confocal and H&E images were available 
from a 750 μm x 750 μm field of view. At each site, the H&E images of fixed tissue specimens 
were used as a reference standard to identify breast architectural features that should be present 
in corresponding confocal images [1, 15]. Benign breast features identified in reference H&E 
images included adipose and fibrous tissue, lobules, non-hyperplastic ducts, and ductal 
hyperplasia. Malignant breast features identified in reference H&E images included: ductal 
carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), and invasive lobular carcinoma 
(ILC).  
6.2.3 Nuclear segmentation and connected components algorithm for identifying nuclei 
A technique called maximally stable extremal regions (MSER) was used to segment 
nuclei from confocal images of proflavine stained breast tissue. MSER has been used previously 
in the image processing community for automatic reconstruction of 3D scenes; here we have 
adapted it to segment nuclei from high resolution fluorescence confocal microscopy images 
[187]. MSER employs intensity thresholding; however, no global or optimal threshold is sought; 
rather all thresholds are tested and the stability of the isolated connected components (i.e. nuclei) 
is evaluated. All possible thresholds from 0 to 255 are applied to an image and the sets of 
connected components (as well as their area) are stored (Figure 6-1:A-D). This yields a data 
structure in which the area of each connected component is stored as a function of the intensity 
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threshold. Finally, the intensity thresholds which correspond to local minima in the rate of 
change of the area function are selected as thresholds producing MSER.  
In order to apply MSER to our images, five tuning parameters associated with MSER had 
to be selected. The first two parameters, which included the minimum area (MinArea) and 
maximum area (MaxArea) of the connected components, are related to the expected size of 
nuclei. These parameters were selected based on the biologically expected range of nuclear 
diameters. Specifically, other groups have found nuclear volume to range from approximately 
200 to 1500 µm3, which corresponds to 7 to 14 µm in diameter [180]. Therefore, MaxArea was 
set to 500 pixels, which corresponds to 19 µm in diameter, which is larger than the expected 
nuclear size for our images. MinArea was set to 35 pixels, which corresponds to 5 µm in 
diameter, which is smaller than the expected nuclear size for our images. The next set of 
parameters is related to the intensity thresholds and includes maximum variation (MaxVariation), 
minimum diversity (MinDiversity), and Delta. MaxVariation is the maximum variation allowed 
within a region that corresponds to a potential nucleus. MinDiversity is employed if there are two 
nested maximally stable regions. Specifically, if the diversity between the two nested regions is 
less than MinDiversity, then the nested region is removed. Lastly, Delta is the stability threshold. 
The stability of a region is defined as the relative variation of the region area when the intensity 
is changed by delta/2. These intensity parameters were systematically tuned through applying a 
range of values to representative images in order to select the best value for each parameter. 
Specifically, one input parameter was varied over a wide range while other input parameters 
were held constant. For each iteration, the area fraction (AF) from representative images of 
tumor and normal tissue was calculated and overlays of the features isolated with that particular 
setting were displayed. 
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Figure 6-1: Algorithms for nuclear (A-D) and ductal (E-L) segmentation. Nuclear segmentation: A: Raw image acquired 
from confocal fluorescence microscope with 750 x 750 µm2 field of view. B: Region of interest selected in confocal 
fluorescence image with 75 x 75 µm2 field of view. C: The maximally stable extremal regions (MSER) algorithm applies 
thresholds from 0 to 255 to B. D: At each threshold, the MSER algorithm identifies nuclei as connected components and 
selects “maximally stable” components with the lowest size variation. Ductal segmentation: E: Raw image acquired from 
confocal fluorescence microscope with 750 x 750 µm2 field of view. F: Wiener low pass filter and adaptive histogram 
equalization applied to E. G: The algorithm converts E to a binary image using an interactive threshold tool. H: Objects 
below range of nuclear area are removed and then user selects a region of interest (ROI) around ducts with an interactive 
polygon selection tool. I: The algorithm fills boundaries of ducts identified in H to segment the outer boundaries of the 
duct. J: The algorithm selects the complement of H to segment the inner boundaries of the duct (lumen). K: Duct wall 
width is measured by selecting the shortest distance from the outer to the inner duct boundaries (red lines). L: Ellipses 
are fitted to outer and inner duct boundaries. E-J: scale bar is 100 µm. K,L: scale bar is 25 µm.  
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The values that led to the largest differences in AF between tumor and normal tissues, 
while isolating features that approximately corresponded to nuclei or nucleoli, were selected. An 
illustration of this tuning approach can be found in Figure 6-2. Specifically, MaxVariation was set 
equal to 2.5, MinDiversity to 0.5, and Delta to 6.  These parameter values are in terms of relative 
intensity, which for our 8 bit images ranges from 0 to 255.  
 
Figure 6-2: Illustration of methodology used to select MSER intensity parameters. The intensity parameters 
MaxVariation, MinDiversity, and Delta were selected by varying each parameter one at a time. The area fraction (AF) 
was calculated for each representative image after each iteration of MSER. Each intensity parameter was plotted as a 
function of AF. Values for the intensity parameters were selected based on which values correctly isolated nuclei from the 
representative images and which values led to the largest differences between tumor and benign images. Scale bar 100 
µm.  
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After nuclei were isolated with MSER, a connected components algorithm was applied in 
order to calculate parameters such as nuclear density and diameter. In the connected components 
algorithm, all touching or connected pixels are assumed to belong to the same cell nucleus. 
Parameters include nuclear density (the number of nuclei in a unit area), area fraction (the total 
nuclear area divided by the total area), minimum internuclear distance (the distance from a 
nucleus center to the next closest nucleus center), and nuclear diameter (the length of the major 
axis of each nucleus). Nuclear density and area fraction (AF) represent scalar variables – only 
one value is returned for each image, while the minimum internuclear distance (IND) and 
nuclear diameter represent vector variables – a value is calculated for each nucleus in the image. 
In order to consolidate the vector variables into a scalar value, several summary statistics were 
evaluated, including mean, median, mode, interquartile range, and standard deviation.  
6.2.4 Ductal segmentation algorithm and quantification of ductal parameters 
An algorithm was developed to measure ductal parameters, which segments non-
hyperplastic ducts, ductal hyperplasia, and DCIS lesions based on the intensity of proflavine 
staining (Figure 6-1:E-L). To reduce noise and increase image contrast, a Wiener lowpass filter 
was first applied (Figure 6-1:E) followed by contrast-limited adaptive histogram equalization 
(CLAHE, Figure 6-1:F). Images were converted from grayscale to binary using a user-defined 
threshold based on relative intensity. The mean threshold used to segment ducts was 107 ± 27 
(range: 52-168) on a scale of 0 to 255 for 8 bit images (Figure 6-1:G). It was not possible to select 
a universal threshold, because in order to accurately segment ducts from surrounding tissue, it is 
necessary to isolate both nuclei in the duct walls and inter-nuclear space between them. The 
relative intensity of these features differed between images due to the variation in illumination 
power used for image acquisition and the variation in proflavine staining. Areas smaller than the 
upper threshold for cell nuclei (approximately equivalent to 280 μm2  or 500 pixels, with a 
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diameter of 19 μm [188]) were removed to avoid segmenting individual nuclei outside of the 
duct walls. Individual ducts were manually segmented using a user-defined polygon selection 
tool to define architectural features corresponding to breast ducts (Figure 6-1:H). After 
application of the ductal segmentation algorithm, the binary confocal image showed the 
segmented duct walls (Figure 6-1:H) and the outer and inner boundaries (Figure 6-1:I,J) of the 
duct used to measure ductal parameters. 
Following segmentation of ducts, a number of ductal parameters were measured based on 
the properties of the inner and outer duct boundaries. The outer boundary defines the outer edge 
of the duct wall and the inner boundary defines the inner edge of the duct wall; the lumen. The 
width of the duct wall was measured at every pixel on the outer edge of the duct wall. This was 
done by finding the shortest distance between every point on the outer boundary and the nearest 
point on the inner boundary (Figure 6-1:K). Duct wall width  was measured for each non-
hyperplastic duct, ductal hyperplasia, and DCIS lesion and the vector of values were summarized 
by calculating the mean, median, mode, interquartile range, and standard deviation. Other scalar 
parameters measured include the area of the duct wall, area of the lumen, area of an ellipse 
approximating the duct wall, area of an ellipse approximating the lumen, lengths of the major 
and minor axes for the duct and the lumen, solidity of the duct and the lumen, and eccentricity of 
the duct and the lumen (Figure 6-1:L).  
6.2.5 Statistical analysis and model building 
Nuclear parameters were calculated for all sites (n = 259) and ductal parameters were 
calculated for all sites that contained ducts (n=50), and the diagnostic performance of each image 
parameter was individually assessed by determining the classification accuracy. Two-class linear 
discriminant analysis was performed to classify malignant from benign breast architectural 
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features based on each individual nuclear or ductal parameter; receiver operator characteristic 
(ROC) curves were constructed and area under the curve (AUC) was calculated for each ROC 
curve. Sensitivity and specificity values were determined at the optimal cutpoint. Parameters 
were sorted by accuracy for classification of neoplasia based on AUC values. Boxplots were 
created for the parameters with the highest AUCs. A Student t-test for samples with unequal 
variances was used to identify statistically significant differences between mean parameter 
values measured in benign and malignant tissues. This analysis was performed to evaluate 
individual nuclear and ductal parameters to incorporate into a classification model.  
Next we sought to develop a multivariate model to yield optimal separation between 
benign and malignant tissues. Towards that end, all 33 nuclear and ductal variables were used as 
input for a classification and regression tree (CART) function in Matlab. Decision trees were 
constructed using the automated Matlab function classregtree, which selects parameters and 
cutpoints that lead to the optimal classification of benign and malignant breast architectural 
features. Decision trees were pruned to prevent a single nuclear or ductal from being used at 
more than one node within the tree. Pruning was also performed to prevent the number of 
categories for classification of malignant breast features from exceeding 3: the number of 
malignant tissue types (IDC, ILC, and DCIS). After construction, decision tree nodes were 
pruned by finding the next higher node whose decision point led to two categories, one with a 
majority of neoplastic sites, and one with a majority of benign sites. A custom leave one out 
cross-validation algorithm was also developed in order to calculate the cross-validated sensitivity 
and specificity. Specifically, 258 of the 259 data points were used to build a CART model, which 
contained the same two variables at the first and second decision points as is seen in Figure 6-6. 
Specifically the standard deviation of IND (StdIND) was the first decision point and the number 
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of lumens was the second decision point. However, with each iteration of leave one out cross-
validation, the cutoff value of StdIND could vary. The cutoff value associated with the number 
of lumens (number of lumens >1) was held constant because biologically normal ducts are 
expected to only contain a single lumen; therefore, this was considered to be the optimal and 
only logical cutoff value and therefore was held constant. Then the model was applied to the 
remaining data point, which was classified as either benign or malignant. This process was 
repeated for all 259 data points, and the calculated diagnosis for each image was compared to the 
known diagnosis in order to calculate sensitivity and specificity for the cross-validated model. 
The performance of the decision tree was characterized by computing sensitivity and specificity 
for classification of malignant breast architectural features. Additionally, sensitivity and 
specificity were calculated for each individual histologic type of malignant tissue in order to 
determine the relative classification accuracy for IDC, ILC, and DCIS sites. For example, in 
order to calculate sensitivity for IDC, true positives were defined as IDC sites that had been 
classifed as malignant by the decision tree, and false negatives were defined as IDC sites that had 
been classified as benign. Specificity was calculated by defining true negatives as benign sites 
that were correctly classified in the decision tree and false positives were defined as benign sites 
that were incorrectly classified. An ROC curve was constructed for the decision tree model in 
Figure 6-6. All sites were sorted in order of ascending StdIND value and then sensitivity and 
specificity for classification of neoplasia were calculated at every StdIND value. The cutoff 
value for number of lumens was held constant at 1 lumen because biologically normal ducts are 
expected to only contain a single lumen. AUC was calculated based on the resulting ROC curve.  
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6.3  Results 
A total of 259 sites from 36 patients were identified in composite confocal fluorescence 
images. A summary of patients, sites, and diagnoses are included in Table 6-1. In total there were 
179 benign sites, which included adipose tissue, fibrous tissue, lobules, and benign ducts, and 80 
malignant sites, which included DCIS, IDC, and ILC.  
Table 6-1: Summary of patients from which tissue specimens were acquired, sites analyzed with segmentation algorithms, 
and histologic diagnoses for each site 
Diagnosis Patients Sites 
Benign   
Adipose tissue 18 42 
Fibrous tissue 16 31 
Lobules 12 82 
Non-hyperplastic ducts 9 20 
Hyperplastic ducts 4 4 
Malignant   
Ductal carcinoma in situ (DCIS) 6 26 
Invasive ductal carcinoma (IDC) 15 37 
Invasive lobular carcinoma (ILC) 3 17 
Total 36 259 
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Figure 6-3: Representative raw confocal fluorescence images of adipose tissue, fibrous tissue, lobules, invasive ductal 
carcinoma, and invasive lobular carcinoma are shown in A through E, respectively. F-J: Nuclei segmented by identifying 
maximally stable extremal regions (MSER) are false colored green and overlaid onto the raw confocal fluorescence image. 
K-O: Histologic slides with H&E staining show similar histology to confocal images in A-E. Slides were prepared with the 
same specimens from which confocal images were acquired. Scale bar is 100 µm. 
 
Figure 6-3 shows representative confocal images of sites without ducts acquired by 
confocal fluorescence microscopy in row 1 and nuclei isolated with MSER at those sites in row 
2. Row 3 of Figure 6-3 shows sites in the corresponding histologic slide with H&E staining that 
have similar histology to the confocal sites.  Nuclei were false-colored green and overlaid onto 
the original images for visualization. As seen, nuclei are isolated at the periphery of adipose cells 
in Figure 6-3F and are dispersed throughout the fibrous tissue image in Figure 6-3G. Denser 
clusters of nuclei are isolated in and around lobules in Figure 6-3H. Nuclei are the most dense at 
sites with malignant tissue, including IDC and ILC (Figure 6-3:I,J).  
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Figure 6-4: Representative confocal images of normal, non-hyperplastic ducts (A), hyperplastic ducts (B), and ductal 
carcinoma in situ (C) analyzed with the nuclear segmentation algorithm (middle row) and with the ductal segmentation 
algorithm (bottom row). D-F: Nuclei segmented by identifying maximally stable extremal regions (MSER) are false 
colored green and overlaid onto the raw confocal fluorescence image. G-I: Breast ducts segmented using the ductal 
segmentation algorithm. J-L: Histologic slides with H&E staining show similar histology to confocal images in A-E. Slides 
were prepared with the same specimens from which confocal images were acquired. Scale bar is 100 µm. 
 
Figure 6-4 shows representative images of breast ducts acquired with confocal 
fluorescence microscopy in row 1, nuclei that were isolated at sites with breast ducts using 
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MSER in row 2, and ducts that were segmented with the ductal segmentation algorithm in row 3. 
Row 4 of Figure 6-4 shows sites in the corresponding histologic slide with H&E staining that 
have similar histology to the confocal sites. Nuclear density in and around the ducts increases 
from the non-hyperplastic duct, to the hyperplastic duct, to DCIS (Figure 6-4: D, E, F). However, 
relatively few nuclei are successfully isolated using MSER within the non-hyperplastic and 
hyperplastic ducts, which is most likely due to the fact that the borders of individual nuclei are 
difficult to visually discern in confocal fluorescence images. The images of sites isolated with 
the ductal segmentation algorithm show well-defined lumens in both the non-hyperplastic duct 
and hyperplastic duct (Figure 6-4G and H). Conversely, the image of DCIS shows bridges of cells 
crossing the lumen to create a cribriform pattern with several lumens.  
The parameters that yielded the highest performance for distinguishing between benign 
and malignant sites are shown in Table 6-2. We evaluated the performance of nuclear parameters 
for classification of benign and malignant features in all sites and in sub-groups of sites that did 
or did not contain ducts to determine the groups for which nuclear parameters had the highest 
classification accuracy.  We only evaluated the classification accuracy of ductal parameters at 
sites that contained ducts. Nuclear parameters measured at non-duct sites achieve higher 
performance (AUC = 0.93) than nuclear parameter measured at duct sites (AUC = 0.69). 
Conversely, ductal parameters achieve higher performance (AUC = 0.92) than nuclear 
parameters for classification of duct sites (AUC = 0.69). These findings suggest that a 
combination of nuclear parameters measured at non-duct sites and ductal parameters measured at 
duct sites may yield improved separation between all benign and malignant sites.   
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Table 6-2: Summary of top performing parameters for distinguishing between benign and malignant sites measured using 
the nuclear and ductal segmentation algorithms. A: Nuclear parameters measured at all sites using the nuclear 
segmentation algorithm. B: Nuclear parameters measured at all sites except those with breast ducts (normal ducts, 
hyperplastic ducts, and ductal carcinoma in situ) using the nuclear segmentation algorithm. C: Nuclear parameters 
measured at sites with breast ducts using the nuclear segmentation algorithm. D: Ductal parameters measured at sites 
with breast ducts using the ductal segmentation algorithm. 
Group Performance 
metric 
Standard deviation 
of inter-nuclear 
distance 
Area fraction Range of inter-
nuclear distance 
A. Classification by Nuclear 
Parameter – All Sites 
AUC 0.87 0.86 0.87 
Sensitivity 78 76 76 
Specificity 82 79 85 
B. Classification by Nuclear 
Parameter – Non-duct Sites 
AUC 0.93 0.92 0.91 
Sensitivity 85 80 81 
Specificity 88 87 88 
C. Classification by Nuclear 
Parameter – Duct Sites 
AUC 0.68 0.72 0.74 
Sensitivity 46 65 62 
Specificity 100 70 96 
Group Performance 
metric 
Number of lumens Minor dimension of 
outer ellipse 
Area of outer 
ellipse 
D. Classification by Duct 
Parameter – Duct Sites 
AUC 0.92 0.83 0.82 
Sensitivity 88 73 81 
Specificity 88 79 75 
 
Boxplots showing the mean and interquartile range of the top three performing nuclear 
parameters are shown in Figure 6-5A-C. Both Std IND and Range IND decrease from adipose to 
fibrous to lobules to ILC to IDC (Figure 6-5A and C), while AF increases from adipose to fibrous 
to lobules to ILC to IDC (Figure 6-5B). This trend suggests that the number of clusters of nuclei 
increases from adipose tissue, which has the fewest, to IDC, which has the greatest number of 
clusters of nuclei. All comparisons between benign (adipose, fibrous, lobules) and malignant 
(IDC, ILC) sites were significant. Similarly, AF increases from adipose to fibrous to lobules to 
IDC (Figure 6-5B), which suggests increasing nuclear density.  
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Figure 6-5: Mean value of parameters used to separate malignant from benign sites. Nuclear parameters calculated with 
the nuclear segmentation algorithm are shown for all adipose, fibrous, lobules, invasive ductal carcinoma (IDC), and 
invasive lobular carcinoma (ILC) sites; A: standard deviation of inter-nuclear distance; B: area fraction; C: range of 
inter-nuclear distance. Ductal parameters calculated with the duct-based segmentation algorithm are shown for all 
normal, non-hyperplastic ducts, hyperplastic ducts (Hyperplasia), and ductal carcinoma in situ (DCIS); D: number of 
lumens; E: minor dimension of outer ellipse; F: area of outer ellipse. The number of sites represented in each box is 
represented by n. Significant differences between mean values of parameters measured at benign and malignant sites are 
indicated by asterisks (*). 
 
Boxplots showing the mean and interquartile range of the top three performing ductal 
parameters for duct sites are shown in Figure 6-5D-F. DCIS lesions have a significantly higher 
number of lumens than hyperplastic and non-hyperplastic ducts (p < 0.001), which is consistent 
with the cribriform pattern that occurs when abnormally high cellular proliferation causes the 
luminal space to be filled with epithelial cells (Figure 6-5 D). Figure 6-5E shows that the minor 
dimension of the outer ellipse approximating the duct is significantly smaller in normal, non-
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hyperplastic ducts than in DCIS lesions (p < 0.001). There is no significant difference in the 
minor dimension between ellipses approximating hyperplastic ducts and DCIS lesions (Figure 
6-5E). Figure 6-5F shows that the area of the outer ellipse approximating duct area was 
significantly smaller in normal, non-hyperplastic ducts than in DCIS lesions (p < 0.001).  There 
is no significant difference between the average area of outer ellipses approximating hyperplastic 
ducts and DCIS lesions (Figure 6-5F).  
All 33 nuclear and ductal parameters were used as input for a classification and 
regression tree (CART) algorithm to automate selection of parameters to discriminate benign and 
malignant sites. The CART algorithm was pruned to remove redundancies and over-fitting to the 
data set. The classification tree generated through this process is shown in Figure 6-6. Std IND 
with a cutoff value of 6.83 µm is the first decision point selected for classification by the 
decision tree, followed by number of lumens with a cutoff value of 1. Std IND < 6.83 µm 
separates out 52 true positives composed of IDC, DCIS, and ILC sties and 9 false positives 
composed of fibrous and lobule sites. The remaining sites enter the second node – Number of 
lumens > 1– which separates out 13 true positive DCIS sites and 3 false positive hyperplasia and 
normal duct sites. The remaining sites are classified as benign and are composed of 167 true 
negative adipose, fibrous, lobule, normal duct, and hyperplasia sites and 15 false positive IDC, 
DCIS, and ILC sites.  
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Figure 6-6: Classification tree automatically generated when all nuclei and duct data was used. Duct- and nuclei-based 
parameters selected by classification regression tree analysis to optimize separation between benign and malignant sites. 
Bar graphs show the diagnoses of sites sorted into each classification category. 
 
Overall, the model achieved a sensitivity and specificity of 81% and 93% respectively, 
corresponding to an area under the curve of 0.93 and 90% overall classification accuracy, as 
shown in Table 6-3. If the model is evaluated based on classification of individual histologic 
types of neoplasia, 92% of IDC sites and 96% of DCIS sites were classified correctly.  However, 
the model correctly classified only 35% of ILC sites. Additionally, leave one out cross-validation 
was performed, which yielded a cross-validated sensitivity of 75% and specificity of 93% (Table 
6-3).  
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Table 6-3: Performance of classification tree model for classification of neoplasia, non-neoplasia, and individual histologic 
types of breast neoplasia in confocal fluorescence images. 
 Sensitivity Specificity 
Classification Tree Model 81% (65/80) 93% (167/179) 
Cross-validated Model 75% (60/80) 93% (167/179) 
 Correctly Classified 
All Sites 90% (232/259) 
DCIS 96% (25/26) 
IDC 92% (34/37) 
ILC 35% (6/17) 
 
Specifically, cross-validation resulted in a 6% drop in sensitivity (from 81% to 75%) due 
to the fact that 5 additional IDC images were incorrectly classified during cross-validation. When 
each of these 5 cases was left out of the original cohort of data used to form the model (in other 
words during the leave one out cross-validation exercise), the cutoff value associated with 
StdIND dropped. This resulted in each of the 5 cases being classified as a false negative. For the 
remainder of the images, the cutoff value associated with StdIND remained the same as it is in 
Figure 6-6, resulting in the same specificity of 93%.   
As seen in the histograms in Figure 6-6, ILC sites account for the largest number of false 
negative (n = 11 out of 17 sites) while lobule sites account for the largest number of false 
positives (n = 8 out of 82 sites). Figure 6-7 shows representative confocal images of a true 
positive ILC, false negative ILC, true negative lobules, and false positive lobules sites in row 1 
and nuclei isolated with MSER at those sites in row 2. Row 3 of Figure 6-7 shows sites in the 
corresponding histologic slide with H&E staining that have similar histology to the confocal 
sites. As seen, there are large differences in the density and clustering of nuclei between the true 
positive ILC site (Figure 6-7E) and true negative lobules site (Figure 6-7G). In comparison to 
Figure 6-7E, the false negative ILC site in Figure 6-7F has relatively few nuclei, which appear to 
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be predominately clustered in the upper left region of the image. Conversely, the false positive 
lobules site in Figure 6-7H contains more nuclei than Figure 6-7G, particularly in stromal tissue 
located in between lobules.  
 
Figure 6-7: Representative images of sites with lowest classification accuracy in the decision tree model. A-D:  invasive 
lobular carcinoma and lobules in confocal fluorescence images. E-H: Nuclei segmented by identifying maximally stable 
extremal regions (MSER) are false colored green and overlaid onto the raw confocal fluorescence image. I-L: Histologic 
slides with H&E staining show similar histology to confocal images in A-E. Slides were prepared with the same specimens 
from which confocal images were acquired. A, E: a true positive invasive lobular carcinoma (ILC) site; B, F: false 
negative ILC site; C, G: true negative lobules; and D, H: false positive lobules. Scale bar is 100 µm.  
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6.4  Discussion 
In this study, we performed quantitative analysis of breast histology in confocal 
fluorescence images by designing algorithms to segment and measure nuclear and ductal 
parameters. We combined nuclear and ductal parameters to develop a classification tree model to 
classify malignant from benign changes in the breast parenchyma with 81% sensitivity and 93% 
specificity, which corresponded to an AUC of 0.93 and an overall accuracy of 90%. The cross-
validated model classified the same sites with 75% sensitivity, 93% specificity, and 88% overall 
accuracy.  
Several groups have used automated morphometric evaluation of nuclei in H&E stained 
sections of breast tissue [171-174], cytological smears of breast tissue [175], and fluorescence 
microscopy images of mouse tissue [179, 185] to classify benign and malignant breast features. 
While these groups demonstrate that quantitative nuclear parameters can be used to classify 
benign and malignant breast features, some lesions are more difficult to distinguish. For 
example, Rajesh et al used automated nuclear morphometry to classify ILC, IDC, and borderline 
lesions [173]. While significant differences were found between parameters measured for ILC 
and IDC, no significant difference was found between parameters measured for ILC and benign 
borderline lesions [173]. We found similar results to the other studies – namely that ILC is 
difficult to distinguish from non-neoplasia based on nuclear features alone. Additionally, several 
studies have demonstrated the feasibility of computerized image analysis to distinguish between 
non-hyperplastic ducts, hyperplastic ducts, and DCIS. Mayr et al used computerized image 
analysis to quantify ductal parameters in H&E-stained slides of breast biopsies and found that the 
most significant parameters for differentiation between normal ducts and DCIS were duct mean 
diameter and the presence of necrosis [176]. Anderson et al used a computerized segmentation 
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algorithm to measure parameters of ductal hyperplasia and DCIS in tissue sections stained with 
the antibody cocktail AE 1/3, and showed that the highest classification accuracy for DCIS was 
achieved by combining parameters of ducts and lumina [177]. The findings from our work agree 
with previous studies, which showed that quantitative ductal parameters can be used to classify 
benign and malignant ducts [176, 177].  
 The strengths of our study are that we demonstrate that nuclear and ductal parameters 
can be measured in confocal fluorescence images of clinical samples acquired at the point of 
care. We perform quantitative analysis of breast tissue architecture without requiring tissue 
fixation, cutting, and staining and achieve comparable classification accuracy to studies that 
performed computerized analysis on fixed breast tissue stained with H&E. The model classified 
IDC and DCIS with greater than 90% accuracy using parameters that were based on the 
morphological characteristics of each malignant tissue type. Specifically, IDC was classified 
with 92% accuracy using standard deviation in inter-nuclear distance as a parameter, which 
identifies dense clusters of nuclei. DCIS was classified with 96% accuracy based on the presence 
of more than one lumen, which is consistent with the cribriform pattern. Overall we achieve high 
performance (AUC = 0.93) on a large number of sites (n = 259).  
There are several limitations associated with this study. While our initial data set contains 
a large number of sites (n = 259), the data was acquired at a single center (The University of 
Texas M.D. Anderson Cancer Center), and some individual categories, such as ILC contain 
relatively few sites (n = 17); therefore, additional work is needed with a large, independent data 
set composed of data from more than one center to validate the feasibility and reproducibility of 
these parameters. However, our initial results indicate that leave one out cross-validation of the 
CART model yields similar performance to the original model suggesting that our model may 
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generalize to an independent data set. Another limitation to the study are the large variances 
observed for the nuclear parameters that reflect the high degree of heterogeneity in nuclear size 
and spacing in benign and malignant breast epithelia. Changes in nuclear area and spacing in 
breast epithelia occur frequently in both ductal and lobular nuclei and can be due to a number of 
clinical features, including sexual maturity, pregnancy, menopausal status, use of hormonal 
contraceptives, and presence of mammary carcinoma [15, 188]. The presence of heterogeneity in 
nuclear area and distribution within benign breast tissue is a potential source of variance for the 
nuclear parameters measured in this study. Similarly, IDC and ILC typically contain irregular 
nuclear sizes and an irregular distribution of nuclei [15, 189], which is another potential source 
of variance within nuclear parameters. In addition, the algorithm designed for ductal 
segmentation uses an interactive threshold to convert images from grayscale to binary and a user-
defined selection tool to isolate ducts from surrounding nuclei. The ductal segmentation process 
is a potential source of variability between users, particularly for parameters that could be 
impacted by a user’s visual assessment of the duct wall boundaries, such as duct wall width. 
However, the ductal parameter that was ultimately selected for the decision tree model was the 
number of lumens, which is unlikely to vary at the decision point (number of lumens greater than 
1) based on slight variations to the threshold value or by excluding surrounding nuclei. This is 
because it is readily apparent if a duct has one or more lumens based on visual assessment, 
however the segmentation algorithm could assist in identifying ducts with more than 1 lumen. 
Lastly, examination of the breakdown of false negatives and false positives reveals that our 
algorithm does most poorly at distinguishing ILC and lobule sites. Specifically 65% (n = 11 out 
of 17 sites) of ILC sites and 10% of lobule sites (n = 8 out of 82 sites) are incorrectly classified. 
Figure 6-7 reveals that there are differences in quantity and clustering of nuclei between the true 
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positive and false negative ILC sites. In particular, nuclei in the false negative ILC site appear to 
be predominately located in the upper left region of the image, suggesting that only the upper left 
region of the image contains ILC while the remainder of the image may contain other benign 
tissue. Therefore, the fraction of the image that consists of a malignant tissue type may correlate 
with the likelihood that it is correctly classified as a true positive site.  Conversely, the false 
positive lobules site contains more nuclei than the true negative lobule site, particularly in 
stromal tissue located in between lobules. This indicates that the stromal tissue that lobules or 
other features are embedded within may lead to incorrect classification as a false positive site. In 
future studies, additional parameters are needed in order to classify lobules as benign and ILC as 
malignant with greater accuracy.  
It is to be noted that while confocal microscopy provides high resolution high quality 
images, currently its cost, footprint, and maintenance requirements limit the ability to translate 
this imaging platform to routine usage in patient care. However, this study lays the groundwork 
for how quantitative analysis could be combined with proflavine staining and fluorescence 
microscopy. Several applications of fluorescence confocal microscopy can certainly evolve in 
pathology practice with the potential availability of a user friendly and affordable platform that 
can be an alternate to currently used modalities for immediate evaluation of fresh tissue. In 
addition, there could be an opportunity to use a low cost fluorescence confocal microscope to 
obtain similar images that may be useful to evaluate fresh tissues in clinical practices with 
limited resources of professional pathology expertise and laboratory infrastructure to obtain 
information from the biopsied tissue to guide clinical management [186, 190].  
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6.5  Conclusions 
We measured quantitative nuclear and ductal parameter in confocal fluorescence images 
of proflavine stained fresh breast tissue and developed a classification algorithm that 
distinguished between 259 benign and malignant sites with an accuracy of 88%. Ultimately, the 
nuclear and ductal parameters described in this study could be used to develop criteria to 
automate breast lesion diagnosis for immediate evaluation of fresh tissue at the point of care 
obviating the need for extensive tissue preparation. Quantitative diagnostic criteria developed on 
fluorescence confocal images in our study have the potential to enable automated assessment of 
breast tissue.  
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7 CHAPTER 7: Confocal fluorescence microscopy to evaluate 
changes in adipocytes in the tumor micro-environment 
associated with invasive ductal carcinoma and ductal carcinoma 
in situ4 
 
ABSTRACT: Adipose tissue is a dynamic organ that provides endocrine, inflammatory, and 
angiogenic factors, which can assist breast carcinoma cells with invasion and metastasis. 
Previous studies have shown that adipocytes adjacent to carcinoma, known as cancer associated 
adipocytes (CAAs), undergo extensive changes that correspond to an “activated phenotype,” 
such as reduced size relative to adipocytes in non-neoplastic breast tissue. Optical imaging 
provides a tool that can be used to characterize adipocyte morphology and other features of the 
tumor microenvironment. In this study, we used confocal fluorescence microscopy to acquire 
images of freshly excised breast tissue stained topically with proflavine. We developed a 
computerized algorithm to identify and quantitatively measure phenotypic properties of 
adipocytes located adjacent to and far from normal collagen, ductal carcinoma in situ (DCIS), 
and invasive ductal carcinoma (IDC). Adipocytes were measured in confocal fluorescence 
images of fresh breast tissue collected from 22 patients. Results show that adipocytes adjacent to 
neoplastic tissue margins have significantly smaller area compared to adipocytes far from the 
margins of neoplastic lesions and compared to adipocytes adjacent to non-neoplastic collagenous 
stroma. These findings suggest that confocal microscopic images can be utilized to evaluate 
phenotypic properties of adipocytes in breast stroma, which may be useful in defining alterations 
in microenvironment that may aid in the development and progression of neoplastic lesions.  
                                                          
4 The contents of this chapter have been submitted for peer review to the International Journal of Cancer 
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7.1 Introduction 
The development of breast cancer is a complex process that primarily occurs in ductal and 
lobular epithelial tissue [22, 23]. However, many recent studies have suggested that breast 
stromal tissue also plays a dynamic and influential role in breast tumor development and 
progression [42-45], and that stromal cell proliferation is a major contributor to increased breast 
cancer risk [52]. Stromal collagen and adipose tissue in particular are of interest for their role in 
breast disease progression [46-51]. It was recently reported that high mammographic density 
(associated with a 4-to-6-fold increase in breast cancer risk) is associated with high collagen 
density [52], which has been shown to directly promote proliferation of mammary epithelial cells 
in vitro and in murine models [47].  
Adipose tissue, the predominant component of benign breast tissue, also functions as a dynamic 
organ that assists breast carcinoma cells with invasion and metastasis by providing endocrine, 
inflammatory, and angiogenic factors [50, 191-193]. Previous studies have shown that co-
culturing adipocytes and cancer cells results in a decrease in adipocyte markers and an 
overexpression of matrix metalloproteinase-11 (MMP-11), an extracellular matrix-remodeling 
proteinase associated with tumor invasion, and interleukin-6 (IL-6), a cytokine associated with 
inflammation [50]. These studies characterize the relationship between invading carcinoma cells 
and adipocytes surrounding carcinoma, commonly referred to as cancer-associated adipocytes 
(CAAs), as a crosstalk cycle, in which adipocytes undergo de-differentiation and contribute to 
abnormal proliferation of tumor cells, which leads to tumor growth and increased invasive 
potential [49, 53, 194].  
Previous research on the role of CAAs and tumor progression also shows that CAAs 
adjacent to neoplastic tissue undergo extensive phenotypic changes, particularly reduced size 
relative to adipocytes in non-neoplastic breast tissue [50, 53]. Tan et al. found that adipocytes 
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near the invasive front of breast tumors tend to be smaller in size than those located further from 
the tumor [49]. Adipocytes co-cultured with breast cancer cells underwent lipolysis and 
developed a fibroblast-like phenotype in which the lipid vesicles greatly decreased in size and 
the cells took on a spindle-shaped appearance [50]. These physical changes observed in 
adipocytes in the tumor microenvironment correspond to an “activated phenotype” [50], which 
could indicate adipocytes that are participating in crosstalk with neoplastic cells and confer 
increased potential for invasion to the tumor microenvironment [49].  
The clinical standard for evaluating breast lesions is histologic assessment, which 
requires extensive tissue preparation and staining with hematoxylin and eosin (H&E). However, 
the standard histologic preparation is not optimal for evaluation of adipose tissue, because 
fixation and sectioning tissue specimens can cause adipocyte cell membranes to tear and adipose 
tissue to slough off or dissolve. Confocal microscopy is an emerging image acquisition technique 
that could potentially address the current limitations of histologic assessment and has been used 
in several previous studies to acquire in vivo images [195-197] of fresh tissue specimens in real 
time [1, 2, 121, 137, 185]. Work from Schiffhauer et al. and Abeytunge et al. demonstrated that 
confocal reflectance microscopy and confocal fluorescence microscopy, can acquire images of 
fresh, unsectioned breast tissue that are visually similar to histologic slides with H&E staining 
[121, 137]. Recent studies from our group showed that confocal fluorescence microscopy images 
of breast tissue acquired in less than ten minutes contain sufficient detail to identify neoplasia 
and non-neoplasia in unsectioned breast tissue specimens [1] and to estimate tumor cellularity in 
core needle biopsies [2]. Currently available endomicroscopy platforms for in vivo imaging, such 
Optiscan FIVE1 (Optiscan, Melbourne, Australia) and Cellvizio® (Mauna Kea Technologies, 
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Paris, France), demonstrate that there is an opportunity to apply confocal microscopy for in vivo 
breast imaging in a clinical setting [195-197].  
 
 The objective of this study is to determine if confocal microscopy can identify and 
characterize changes in adipocyte phenotype near the margins of invasive breast cancer and pre-
invasive lesions. Although the reduced size of CAAs adjacent to breast tumors has been 
qualitatively observed, this phenomenon has not been quantitatively evaluated. In this study we 
used confocal fluorescence microscopy to acquire images of adipose tissue located near 
neoplastic tissue as well as adipocytes near non-neoplastic collagenous stroma in fresh, unfixed 
breast tissue. The findings from this study support further use of confocal microscopy as a point 
of care tool to image breast tumors and surrounding adipose tissue and to explore whether 
features of adjacent adipocytes can predict the invasive potential of early breast cancers.  
7.2  Materials and Methods 
7.2.1 Breast tissue acquisition and preparation 
Human breast tissue specimens were acquired through a protocol approved by the 
institutional review boards at The University of Texas MD Anderson Cancer Center and Rice 
University. All specimens were acquired from patients who gave informed consent to participate 
in the study. Patients were eligible for the study if they were undergoing a total or segmental 
mastectomy for breast cancer. Fresh tissue specimens were acquired from residual resected 
breast tissues that were not required for clinical diagnosis.  Two tissue specimens measuring 
approximately 15 x 15 x 2-7 mm were acquired from each patient within 30 minutes of resection, 
including one grossly normal specimen and one grossly abnormal specimen. Each tissue 
specimen was stained with a solution of 0.01% proflavine in 1X phosphate buffered saline (PBS) 
for 1 minute, washed in 1X PBS, and then immediately imaged using a confocal fluorescence 
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microscope. Proflavine has been used in previous studies as a fluorescent contrast agent to stain 
nuclei in breast tissue, oral mucosa, esophageal tissue, cervical tissue, and sarcoma [1, 2, 102, 
122, 183-186, 198, 199]. Proflavine also non-specifically stains the membranes of adipocyte 
cells [1], which makes it possible to identify adipocytes without using a contrast agent to stain 
lipid droplets. 
7.2.2 Image acquisition and evaluation 
Fluorescence confocal images were acquired with a benchtop confocal microscope 
(Vivascope 2500, Caliber I.D.).  Following topical application of proflavine, specimens were 
positioned on the microscope stage and imaged with 2.1 ± 0.4 mW power at 488 nm laser 
excitation using a 30X water immersion objective lens with a numerical aperture of 0.8. The 
confocal microscope has a 750 x 750 µm  field of view (FOV) with 1.0 µm lateral resolution and 
5.0 µm axial resolution. Images were acquired at a focal plane depth approximately 20 µm 
beneath the tissue surface from a composite grid of contiguous sites with a total area of 12.2 x 
12.2 mm [1]. Composite confocal images required approximately 10 minutes to acquire. After 
image acquisition, tissue specimens were submitted for routine histologic preparation and 
fixation with H&E staining.  
A breast pathologist reviewed the confocal and H&E stained images to provide a 
diagnosis for each tissue specimen based on standard histologic criteria [15]. We used images 
with H&E staining to identify regions with adipose tissue surrounding invasive ductal carcinoma 
(IDC), ductal carcinoma in situ (DCIS), and stromal collagen with no neoplastic cells (collagen), 
and located the same regions in confocal images. During the pathologist’s review of composite 
confocal images and corresponding H&E stained sections we verified that the images were 
acquired from the same approximate location within the specimen if they contained similar 
morphology. It was not possible to image the identical section of tissue with the confocal 
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microscope that was stained with H&E, because the specimens imaged with the confocal 
microscope were not sectioned; specimens were sectioned during routine histologic preparation.  
In confocal images, we defined regions of interest (ROIs) in confocal images consisting of two to 
four contiguous FOVs, originating at the margin of IDC, DCIS, or collagen without neoplasia 
and extending 2 - 3 mm into adipose tissue (Figure 7-1);  2 -3 mm is  a narrow tumor resection 
margin typically used in breast-conserving surgeries [200]. 
 
Figure 7-1: Schematic of the procedure used to identify regions of interest (ROIs) within adipose tissue at the margin of 
invasive tumors. Regions with adipose tissue adjacent to invasive tumors were identified in images of fixed tissue 
specimens stained with hematoxylin and eosin using standard histologic criteria (top left). The same regions were 
identified in the corresponding image acquired with confocal fluorescence microscopy (top right). White squares in upper 
right image indicate 4 contiguous FOVs adjacent to an invasive tumor margin. Scale bar is 750 µm. In the bottom image, 
boxes with dashed lines indicate four contiguous 750 x 750 µm FOVs next to the invasive tumor margin and extending up 
to 3 mm into adipose tissue. Scale bar is 3 mm. 
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7.2.3 Adipocyte segmentation algorithm and measurement of adipocyte nuclei 
We developed a computerized algorithm in MATLAB® (R2011b, MathWorks®) to 
segment adipocytes and characterize adipocyte morphology in confocal images of breast tissue, 
as shown in Figure 7-2. Adaptive histogram equalization was applied to unprocessed confocal 
images (Figure 7-2A)to enhance the brightness of the adipocyte cell membranes (Figure 7-2B). 
Since proflavine preferentially stains nuclear material and does not stain lipid droplets, 
adipocytes appeared as unstained areas surrounded by non-specifically stained cell membranes in 
confocal images [1, 122].  Adipocyte membranes were detected and enhanced using a 
combination of two morphological operations implemented with the “bwmorph” and “imdilate” 
functions (Figure 7-2C). The contrast-enhanced confocal image (Figure 7-2B) was converted to a 
binary image with a user-defined threshold based on relative staining intensity of adipocyte cell 
membranes (Figure 7-2D). The resulting binary image (Figure 7-2D) was overlaid onto the 
adipocyte cell membranes previously segmented with a combination of morphological operations 
(Figure 7-2C) using a logical OR operation (Figure 7-2E). A morphological closing function 
(imclose) was used to dilate and then erode the image with a disk-shaped structuring element to 
fill the gaps where adipocyte cell membranes were incompletely segmented by the previous 
operations (Figure 7-2F). In order to identify adipocytes enclosed by adipocyte cell membranes, a 
complement function reversed the background and segmented areas (colored black and white, 
respectively) in the binary image (Figure 7-2G). A morphological opening function  (imopen) was 
used to perform erosion followed by dilation with a disk-shaped structuring element to remove 
objects smaller than adipocytes; the structuring element was designed to remove regions that 
were smaller than 1.5X the area of a large mammary carcinoma cell; this area was 338 µm , 
slightly larger than the size of a large epithelial cell within mammary carcinoma [188] (Figure 
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7-2H). To avoid measuring areas of adipocytes which were cut off by the border of the FOV, an 
image processing function (imclearborder) was applied to delete objects connected to the borders 
of the image (Figure 7-2I). Following segmentation of adipocytes, an ellipse was fitted to each 
adipocyte to approximate its cross-sectional area. The mean ellipse area was calculated for each 
consecutive FOV in ROIs. 
The adipocyte segmentation algorithm was modified to segment adipocytes in histologic 
images with H&E staining. Unlike in confocal images, in which adipocytes appear as dark, 
unstained areas, adipocytes in digital images of histologic slides appear as white areas unstained 
by H&E. Thus, in the modified algorithm adipocytes were identified as areas with higher signal. 
The complement function described in the first iteration was omitted, because cell membranes 
stained with H&E already had lower signal than the lipid droplets.      
After processing, each FOV was manually reviewed to determine if the algorithm 
accurately segmented adipocytes compared to visual examination. We developed additional 
manual interactive functions to improve segmentation of individual adipocytes that were not 
accurately identified by the algorithm. For example, in FOVs with very weakly-stained cell 
membranes, clusters of cells were occasionally incorrectly segmented as a single adipocyte. 
Additionally, out of focus cell membranes in a FOV sometimes caused an individual adipocyte 
to be separated into multiple fragments.  In these cases, the interactive functions were used to 
separate clusters of cells into individual adipocytes or to connect fragments of a cell into a single 
adipocyte. All FOVs required manual adjustment to improve segmentation accuracy for at least 
one adipocyte.  
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We compared the morphology of adipocytes at the margins of IDC and DCIS to those 
extending into surrounding stroma. We also compared the morphology of adipocytes at these 
ROIs to adipocytes surrounding stromal collagen in areas that did not contain neoplasia. 
Statistical comparisons were made using an ANOVA test with a Bonferroni-Holm post-hoc test.  
 
Figure 7-2: Adipocyte segmentation algorithm. A: Original confocal fluorescence image. B: Adaptive histogram 
equalization to enhance brightness of adipocyte cell membranes. C: Adipocyte cell membrane edges detected and 
enhanced. D: Image A is converted to binary. E: Binary image D and enhanced edges in image C are combined. F: 
Closing function is applied to fill gaps in adipocyte cell membranes. G: Background (black) and segmented areas (white) 
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are reversed to create the complement of F. H: Opening function is applied to remove objects smaller than 1.5X the area 
of a large mammary carcinoma cell. I: Objects touching the image border are removed. Scale bar is 100 µm.  
 
7.3 Results 
Adipocytes were measured in 427 FOVs within 116 ROIs in composite confocal 
fluorescence images of breast tissue specimens collected from 22 patients. A summary of FOVs, 
ROIs, patients and diagnoses are shown in Table 7-1.  Each FOV required approximately 20 
minutes for adipocyte segmentation with the computerized algorithm and manual functions.  
Table 7-1: Summary of patients from which tissue specimens were acquired and regions of interest (ROIs) adjacent to 
lesion margins consisting of 2-4 contiguous FOVs, with corresponding histologic diagnoses. 
Diagnosis Patients ROIs FOVs 
IDC  22 54 187 
DCIS 2 9 31 
Collagen 22 53 209 
All 22 116 427 
 
Figure 7-3 shows representative ROIs that consist of 4 contiguous FOVs from specimens 
with IDC (Figure 7-3A), DCIS (Figure 7-3B), and collagen in a non-neoplastic region (Figure 
7-3C). FOVs labeled with I are located adjacent to IDC, DCIS, or collagen; the adjacent sets of 
contiguous FOVs (Figure 7-3A-C: II-IV) extend into adipose tissue. FOVs labeled with IV are 
located between 2 and 3 mm from the lesion edge (Figure 7-3A-C:I) and represent a theoretical 
narrow resection margin [200]. Figure 7-3D shows mean adipocyte ellipse area measured in each 
FOV (Figure 7-3A-C) using the segmentation algorithm. Adipocytes in FOVs adjacent to IDC 
and DCIS (Figure 7-3A,B: I; Figure 3D) have a mean area of approximately 5,000 µm , while 
adipocytes in the FOV adjacent to benign collagen (Figure 7-3C) have a mean area of 
approximately 9,000 µm . Mean adipocyte area increases to over 24,000 µm  in FOVs 2-3 mm 
from the margin of the IDC lesion and to 12,000 µm  for the DCIS lesion (Figure 7-3A,B: II-IV; 
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Figure 7-3D). In contrast, mean adipocyte area stays relatively constant over the distance from the 
interface with collagen in the non-neoplastic region.  
 
Figure 7-3: Representative regions of interest (ROIs) consisting of 4 contiguous FOVs located adjacent to the margins of 
invasive ductal carcinoma (A), ductal carcinoma in situ (B), and benign collagen (C). I: 750 x 750 µm FOVs located 
adjacent to non-adipose tissue margins. II-IV: contiguous FOVs extending up to 3 mm into adipose tissue. Scale bar is 100 
µm. (D) Mean adipocyte ellipse area measured for each FOV shown above using the adipocyte segmentation algorithm.  
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Figure 7-4 shows the mean adipocyte area versus distance from the margin for all 427 
FOVs. Figure 7-4A shows that on average adipocytes adjacent to the margin of IDC are smaller 
than those adjacent to benign collagen, whereas the mean size of adipocytes is similar at 2-3 mm 
from the margin. Although the number of samples is smaller, a similar trend is seen for DCIS, 
with small adipocytes near the margin, increasing in size at 2-3 mm distant from the margin. 
Figure 7-4B shows the same mean adipocyte area versus distance from the margins, but data have 
been normalized by the mean value from the FOV immediately adjacent to IDC, DCIS, and 
benign collagen. Adipocytes show the greatest increase in mean area in FOVs identified in IDC 
specimens: adipocytes in contiguous FOVs extending into adipose tissue have an average of 
1.8X (range: 0.77-6.4X) the mean area of adipocytes in FOVs adjacent to IDC margins (Figure 
7-4B).  In tissue with DCIS, adipocytes in FOVs extending into adipose tissue have an average of 
1.6X (range: 0.86-2.5X) the mean area of adipocytes in FOVs adjacent to DCIS margins. In 
benign stroma, adipocytes in FOVs extending into adipose tissue have an average of 1.3X 
(range: 0.21-3.8X) the mean area of adipocytes in FOVs adjacent to benign collagen.  
Figure 7-4C shows box and whiskers plots summarizing the distribution of mean 
adipocyte ellipse area in FOVs versus distance from the margin. Significant differences in mean 
area identified with an ANOVA test and a Bonferroni-Holm post-hoc test are identified with 
asterisks (*) and the dagger symbol (†). Adipocytes in FOVs adjacent to IDC and DCIS have 
significantly lower mean area than adipocytes in FOVs adjacent to benign collagen (p < 0.001 
and p < 0.05, respectively). There was no significant difference in mean area between adipocytes 
measured 2-3 mm away from benign collagen and IDC or between adipocytes 2-3 mm from 
benign collagen and DCIS. In addition, adipocytes in FOVs adjacent to margins of IDC or DCIS 
have significantly lower mean area than in FOVs located further from the associated lesion 
131 
 
margins (2.2X-fold increase in area corresponding to p < 0.001 for IDC, 2.0X-fold increase in 
area corresponding to p < 0.001 for DCIS). Adipocytes in FOVs adjacent to benign collagen also 
have significantly lower mean area than adipocytes 2-3 mm into adipose tissue (1.2X-fold 
increase in area corresponding to p < 0.01).  
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Figure 7-4: A: Mean adipocyte ellipse area measured for each FOV, measured adjacent to the lesion edge (I) and 
extending into adipose tissue (II-IV) for tissue adjacent to IDC, DCIS and benign collagen. B: Mean adipocyte ellipse area 
measured for each FOV extending into adipose tissue (II-IV), normalized to the FOV adjacent to the lesion edge (I); 
ellipse area measured in tissue adjacent to IDC, DCIS and benign collagen. C: Box and whiskers plot showing mean 
adipocyte ellipse area, measured adjacent to the lesion edge (I) and extending into adipose tissue (II-IV), for ROIs 
adjacent to IDC, DCIS, and benign collagen. Asterisks (*) above the boxes indicate significant differences between the 
mean ellipse area measured for the site adjacent to the lesion edge (I) and sites extending into adipose tissue (II-IV); * = p 
< 0.05; ** = p < 0.01; *** = p < 0.001. The symbols (†) indicate significant differences between the mean ellipse area 
measured in sites adjacent to collagen compared to sites adjacent to IDC and DCIS (††† = p < 0.001). 
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The segmentation algorithm was adapted to identify and measure parameters of 
adipocytes in histologic images with H&E staining. Figure 7-5 shows representative FOVs in 
histologic slides and confocal images identified at the same approximate location within a breast 
tumor specimen, adjacent to the tumor edge (Figure 7-5 A,C) and 2 mm from the tumor edge 
(Figure 7-5 B,D). The top row of Figure 5 shows the original histologic and confocal images and 
the bottom row shows images following application of the segmentation algorithm. The box and 
whiskers plot (Figure 7-5 E) compares adipocyte ellipse area measured in the FOVs shown in 
Figure 7-5 A-D. Adipocyte area is not significantly different between the histologic and confocal 
images adjacent to the tumor center. In both histologic and confocal images adipocyte area is 
significantly smaller adjacent to the tumor edge than 2 mm from the tumor edge.  
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Figure 7-5: Adipocytes segmented in histologic slides with H&E staining (A,B) and confocal images of tissue stained with 
proflavine (C,D). FOVs in histologic and confocal images were identified at the same approximate locations within a 
breast tissue specimen. FOVs show adipocytes adjacent to the tumor edge (A,C) and a distance of 2 - 3 mm from the 
tumor edge (B,D). Arrowheads indicate adipocytes with torn cell membranes. The boxplot shows adipocyte ellipse area 
measured at FOVs shown in A-D (E). The FOV corresponding to each box and the location of the FOV relative to the 
tumor edge is indicated below the plot. Scale bars are 100 µm. 
 
7.4  Discussion 
In this study, we developed a computerized algorithm to identify and quantitatively 
characterize adipocytes in confocal fluorescence microscopy images of fresh breast tissue. 
Images were acquired from fresh breast tissue prior to standard histologic preparation and 
fixation and the algorithm was used to analyze characteristics of adipocytes at sites adjacent to 
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and far from lesion margins in neoplastic and non-neoplastic tissue. We found that adipocytes 
adjacent to neoplastic tissue margins are significantly smaller in area compared to adipocytes far 
from the margins of neoplastic lesions and compared to adjacent to non-neoplastic collagenous 
stroma. Applying the segmentation algorithm to representative ROIs in histologic and confocal 
images shows that there is no significant difference in mean adipocyte area adjacent to the tumor 
edge, and that the adipocyte size increases significantly 2 mm away from the tumor edge. 
However, confocal images showed a greater increase in adipocyte size than did H&E stained 
histologic slide; this could be a result of differential tissue shrinkage following fixation. 
Our observations are consistent with previous studies of histologic images of breast lesions 
by Tan et al. and Dirat et al., which have qualitatively observed that adipocytes adjacent to 
neoplastic breast lesions show phenotypic changes, such as smaller area [49, 50]. These studies 
also suggest that adipocytes adjacent to neoplastic breast lesions are elongated in shape; although 
we measured cell eccentricity as a metric of adipocyte shape, we did not observe significant 
differences in adipocyte shape adjacent to neoplastic or non-neoplastic lesions.  
A strength of our study is that we demonstrate that adipocytes can be evaluated in confocal 
fluorescence images of fresh tissue specimens. Early computational methods to approximate 
adipocyte cross-sectional area include manual cell counting and measurements from cell 
suspensions and H&E stained histologic sections [201, 202]. Additionally some previous studies 
have demonstrated automated algorithms for adipocyte segmentation in cell suspension and 
H&E-stained histologic slides [203-205]. Björnheden et al. developed a method to determine 
human adipocyte size in a cell suspension [203]. Chen et al. and Osman et al. demonstrated 
automated computerized methods to determine adipocyte size in histologic slides of murine 
tissue or human tissue. Both studies describe automated algorithms using image processing 
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software to measure cross-sectional area of adipocytes [204, 205], which used similar functions 
to those incorporated in the algorithm described in this study. In our study we evaluated 
adipocyte cross-sectional area in fresh tissues, which did not undergo fixation and preparation 
that could alter adipocyte phenotype. This algorithm could potentially be used to segment 
adipocytes in images covering a larger field of view, provided that images had sufficient 
resolution for adipocyte membranes to be identified. While frozen section and touch preparation 
are currently used to prepare tissue for evaluation, these techniques can cause distortion of breast 
tissue specimens with adipose tissue, particularly in cases in which core needle biopsies are 
obtained. Damage to adipocyte cell membranes can also occur during routine histologic 
preparation and fixation prior to H&E staining; for example, torn cell membranes are indicated 
by the arrowheads in Figure 7-5B.  
This study has some limitations. The computerized algorithm incorporates a user-defined 
threshold to convert images to binary in order to segment and measure adipocytes. The variable 
threshold was needed to account for differences in fluorescence intensity, which are based on 
several factors, including the variation in illumination power used for image acquisition and the 
presence of background fluorescence from out of focus signal. Additionally the histologic types 
of breast malignancies represented in this study only included IDC and DCIS and there were 
very few tissue specimens acquired from patients with DCIS lesions.  Future studies should 
investigate adipocyte phenotype adjacent to a greater variety of breast malignancies. In this study 
tissue collection was limited to malignant tissue and specimens consisting of predominantly 
adipose tissue. Future studies could also be performed with a greater focus on adipocyte 
phenotype adjacent to benign proliferative lesions, such as sclerosing adenosis and reactive 
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changes at biopsy sites. Additional work is also needed to elucidate the molecular basis for the 
changes in adipocyte characteristics associated with IDC and DCIS observed in this study.  
 
Our findings support previous observations that there is a change in adipocyte phenotype at 
the margins of neoplastic breast lesions, including IDC and DCIS [49, 50]. We demonstrate that 
adipocyte parameters could potentially characterize the microenvironment of early neoplastic 
breast cancers and suggest potential for lesion growth and local invasion. However, additional 
work is needed to analyze adipocyte phenotypes in breast tissue acquired from a larger cohort of 
patients and in a wider range of neoplastic and non-neoplastic breast lesions.  
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8 CHAPTER 8: High Resolution Microendoscopy with Structured 
Illumination and Lugol’s Iodine Staining for Evaluation of 
Breast Cancer  
 
ABSTRACT: Intraoperative margin assessment to evaluate resected tissue margins for neoplastic 
tissue is performed to prevent reoperations following breast-conserving surgery. High resolution 
microendoscopy (HRME) can rapidly acquire images of fresh tissue specimens, but is limited by 
low image contrast in tissues with high optical scattering. In this study we evaluated two 
techniques to reduce out-of-focus light: HRME image acquisition with structured illumination 
(SI-HRME) and topical application of Lugol’s Iodine. Fresh breast tissue specimens from 19 
patients were stained with proflavine alone or Lugol’s Iodine and proflavine. Images of tissue 
specimens were acquired using a confocal microscope and an HRME system with and without 
structured illumination. Images were evaluated based on visual and quantitative assessment of 
image contrast. The highest mean contrast was measured in confocal images stained with 
proflavine. Contrast was significantly lower in HRME images stained with proflavine; however, 
incorporation of structured illumination significantly increased contrast in HRME images to 
levels comparable to that in confocal images. The addition of Lugol’s Iodine did not increase 
mean contrast significantly for HRME or SI-HRME images. These findings suggest that 
structured illumination could potentially be used to increase contrast in HRME images of breast 
tissue for rapid image acquisition. 
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8.1 Introduction 
 The clinical standard to manage early stage breast cancers is surgical excision in breast 
conserving surgery. After surgical excision, positive margin status is an indicator increased risk 
of local tumor recurrence [206-208]. Current techniques to intraoperatively evaluate margins of 
excised specimens include touch preparation cytology and frozen section analysis [152-154, 
209]. However, touch preparation does not preserve cell orientation and arrangement relative to 
the lesion or microenvironment in excised specimens [144]. Frozen section has the potential to 
lose or damage valuable tissue during rapid freezing and cutting required to prepare slides [113, 
155]. The need for new imaging methods to intraoperatively evaluate margins of breast tumors 
has motivated several studies evaluating potential techniques, including optical coherence 
tomography (OCT), radiofrequency spectroscopy, and intraoperative ultrasound [91, 93, 94, 155, 
156]. Several studies have shown that confocal microscopy could potentially be used to rapidly 
evaluate breast tissue specimens intraoperatively [1-3, 121, 137]. However, confocal microscopy 
systems are generally too expensive for breast tissue imaging settings with limited economic or 
personnel resources.  
High resolution microendoscopy (HRME) is a low cost tool that can be used to acquire 
images of unfixed tissue [138, 181, 182, 184, 210], but it can be limited by high background 
signal in tissues with high optical scattering [108, 186]. A previous study showed that using 
structured illumination can be used to reduce background light in images acquired with an 
HRME system [105]. Several studies have also demonstrated that incorporating structured 
illumination into the HRME system has the potential to improve image quality and enhance 
recognition of architectural features in murine mammary glands and in human tissues with 
cervical cancer [107-109, 186]. Another approach to absorb out-of-focus light is application of 
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Lugol’s Iodine, which is used as a topical antiseptic in clinical cervical cancer imaging [211, 
212]. Numerous in vitro and in vivo studies have shown that Lugol’s Iodine can assist with 
differentiation between neoplastic and non-neoplastic cells in cervical, oral, and esophageal sites 
[211-219]. 
The objective of this study was to evaluate microendoscopy with structured illumination 
and Lugol’s Iodine as methods to improve contrast in HRME images of fresh breast tissue. We 
evaluated images based on visual assessment of breast architectural features and on quantitative 
measurement of image contrast to determine if image acquisition with structured illumination 
and topical application of Lugol’s Iodine improve image contrast. Our findings indicate that 
HRME with structured illumination (SI-HRME) yields images with significantly higher contrast 
relative to images acquired using HRME with standard illumination. Visual assessment of 
HRME and SI-HRME images of neoplastic tissue indicated that topical application of Lugol’s 
Iodine reduced background fluorescence. However, application of Lugol’s Iodine did not 
significantly increase mean contrast in HRME or SI-HRME images. Additional studies with 
larger numbers of patients are needed to validate SI-HRME to determine if images acquired with 
this illumination technique contain sufficient information to identify neoplastic breast lesions.  
8.2  Materials and Methods 
8.2.1 Tissue acquisition and preparation 
Human breast tissue specimens were acquired through a protocol approved by the 
institutional review boards at M.D. Anderson Cancer Center and Rice University. Patients were 
eligible to participate in the study if they provided informed consent and were undergoing 
surgery to remove breast cancer. Breast tissue specimens (approximately 1.5 x 1.5. x 0.8 mm) 
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were selected from regions of grossly normal- and abnormal-appearing tissue within 30 minutes 
of resection.  
Prior to imaging, all breast tissue specimens were stained with proflavine, a contrast 
agent that stains cell nuclei, which was topically applied as a 0.01% solution in 1x (phosphate-
buffered saline) PBS for 1 minute followed by a wash with 1x PBS. Breast tissue was stained 
with proflavine alone at 57 sites and with Lugol’s Iodine and proflavine at 13 sites. Following 
application of proflavine, a solution of 2% Lugol’s Iodine was applied to human breast 
specimens through a transfer pipette followed by a wash with 1x PBS. Proflavine was re-applied 
after staining with Lugol’s Iodine to increase the intensity of fluorescence signal from epithelial 
cell nuclei.   
 Application of Lugol’s Iodine, a topical antiseptic that has been shown to stain non-
neoplastic tissues a dark brown color [213], was evaluated as an approach to improve image 
contrast by reducing transmission of out-of-focus light. In order to determine an appropriate 
concentration of Lugol’s Iodine, we tested different concentrations ranging from 1 to 5% using 
murine mammary glands. Visual assessment of HRME and SI-HRME images of murine 
mammary glands stained with proflavine and Lugol’s Iodine indicated that a concentration of 2% 
Lugol’s Iodine provided the best balance between improvement in image contrast and reduction 
in proflavine intensity (data not shown). 
8.2.2 Image acquisition: confocal fluorescence microscope, HRME, SI-HRME 
At each site, a corresponding set of images was acquired with the confocal microscope 
and the microendoscopy system with and without structured illumination (SI-HRME and HRME 
images, respectively). Confocal fluorescence images were acquired of tissue specimens stained 
with proflavine. Confocal images were used to identify potential sites of interest, to guide fiber 
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optic probe placement for image acquisition with the combined HRME and SI-HRME system, 
and as a benchmark for image contrast attainable with the microendoscope system. High 
resolution microendoscopy (HRME) images and HRME images with structured illumination (SI-
HRME) were acquired following confocal image acquisition of proflavine-stained breast 
specimens and in a subset of samples again after application of Lugol’s Iodine. During Lugol’s 
Iodine application and re-application of proflavine, the fiber optic probe was retracted and held 
stationary above the imaging site, and then the probe was lowered to acquire HRME and SI-
HRME images at the same site as the previously acquired pair of images. 
Confocal fluorescence images were acquired from all human breast specimens using a 
scanning confocal microscope (Vivascope 2500®; Caliber Imaging and Diagnostics Inc., 
Rochester, New York) as described previously [1-3]. After topical application of proflavine, each 
specimen was positioned on the confocal microscope stage and imaged at 2.1 ± 0.4 mW at 488 
nm laser excitation with a 550 ± 44 nm bandpass filter through a 30X water immersion lens 
(numerical aperture = 0.8). At the center of each 750 x 750 µm  field of view, the lateral 
resolution of confocal images is 1.0 µm and axial resolution is 5.0 µm. The microscope acquired 
images in a grid pattern, and images were assembled into a 12.2 x 12.2 mm composite image 
following acquisition.  
We used a compact, high resolution microendoscopy system (HRME) that can employ 
structured illumination (SI-HRME) [107, 108] to acquire HRME and SI-HRME images of sites 
within tissue specimens. The HRME/SI-HRME system incorporates a 10 lp/mm grid, condenser 
lens, and motorized translation stage into the previously described HRME system [99-102, 122, 
138, 181, 210]. During HRME image acquisition, when the 10 lp/mm grid is outside the optical 
path, images have 4.0 µm lateral resolution and 120 µm predicted axial response based on an 
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experiment measuring the decrease in mean signal intensity as a function of the distance between 
the fiber bundle and fluorescence source [108, 190]. During SI-HRME image acquisition, the 
stage holding the 10 lp/mm grid is shifted in front of the optical path and a grid is projected onto 
the fiber bundle in steps of 1/3 period, giving SI-HRME images 4.0 µm lateral resolution and 70 
µm predicted axial response [108, 190]. The hardware and software for image acquisition in the 
HRME/SI-HRME system are synchronized using a custom LabVIEW program, which provides 
controls for user-defined exposure, gain, and file saving. The speed of image acquisition is 
reliant on the frame rate of the camera; the maximum frame rate is 11 FPS for HRME images 
and 3 FPS for SI-HRME images. The fiber optic probe was placed at a selected site and held 
stationary during HRME and SI-HRME image acquisition. Following image acquisition, breast 
tissue specimens were submitted for standard fixation and histologic slide preparation with 
hematoxylin and eosin (H&E) staining to serve as a reference standard for histologic diagnosis.  
8.2.3 Evaluation of HRME, SI-HRME, and confocal images  
HRME and SI-HRME images were visually compared to confocal images and sites with 
similar architectural features within histologic images acquired from the same specimens. A 
board-certified breast pathologist assigned a diagnosis by viewing histologic slides of specimens 
stained with H&E on a conventional light microscope. The pathologist then verified that images 
acquired with optical imaging modalities showed similar image morphology to histologic images 
by viewing composite confocal, HRME, and SI-HRME images on a computer monitor. 
To compare contrast in images acquired with HRME and SI-HRME using Lugol’s Iodine 
and proflavine, we calculated image contrast for each image. Confocal fluorescence image were 
used as a reference standard. HRME and SI-HRME images were cropped to a 560 x 560 µm 
ROI; the largest maximum square area that could fit within the circular fiber bundle. Confocal 
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images were also cropped to a 560 x 560 µm ROI.  Contrast was calculated from gray-level co-
occurrence matrices (GLCMs), a commonly used tool to characterize image texture based on 
spatial relationships between pairs of pixels [220]. Contrast describes the difference in pixel 
intensity between neighboring elements:  
∑ 𝑃𝑖𝑗(𝑖 − 𝑗)2
𝑁−1
𝑖,𝑗=0
 
in which j and j specify location within the GLCM and Pij is the intensity level of the element at 
i,j. N specifies the number of grayscale intensity levels; between 2 to 256 for an 8-bit image. 
When contrast is equal to 0, the elements within the GLCM have constant intensity. HRME and 
SI-HRME images were filtered with a Gaussian low pass filter in order to remove the fiber 
bundle pattern projected onto the images. Pairs of pixels were evaluated over an offset of 14 
pixels, which corresponds to 10 µm, the average diameter of a non-neoplastic breast cell nucleus 
[188]. In order to accurately compare contrast between images that had been acquired with 
different levels of laser power, the mean intensity for all HRME, SI-HRME, and confocal images 
was normalized to 50 (on an intensity scale of  0 to 255 for 8-bit images).  In order to compare 
relative values of contrast between imaging modalities and contrast agents applied, GLCM-based 
contrast measurements were normalized to the maximum value of contrast measured. The same 
normalization was applied to images acquired with all imaging modalities and contrast agents.  
ANOVA was performed to evaluate equal variance and a Bonferroni—Holm posthoc test was 
performed to analyze differences between mean values of GLCM-based contrast for HRME, SI-
HRME, and confocal images. 
145 
 
8.3 Results 
Human breast tissue samples were collected from a total of 19 patients, and matching 
histologic features were identified in sets of HRME, SI-HRME, and confocal images acquired at 
70 sites (Table 8-1). Non-neoplastic tissue was identified in 47 sites, which included adipose and 
fibrous tissue, lobules, and benign phyllodes, a benign cytosarcoma lesion. Neoplastic tissue was 
identified in 23 sites, and diagnoses included ductal carcinoma in situ (DCIS) and invasive ductal 
carcinoma (IDC).  
Table 8-1: Summary of sites and proflavine-stained tissue types evaluated in HRME, SI-HRME, and confocal images 
Patients 19 
Sites 70 
proflavine only 57 
Lugol’s Iodine and proflavine 13 
Non-neoplastic tissue Sites: 47 
Adipose tissue 19 
Fibrous tissue 17 
Lobules 10 
Benign phyllodes 1 
Neoplastic Sites: 23 
Ductal carcinoma in situ (DCIS) 3 
Invasive ductal carcinoma (IDC) 20 
 
Figure 8-1 shows representative neoplastic and non-neoplastic breast features in HRME, 
SI-HRME, confocal fluorescence images, and conventional histologic slides with H&E staining. 
The top row of Figure 8-1 shows images of adipose tissue containing a blood vessel; the blood 
vessel can be recognized in all imaging modalities. The second row of Figure 8-1 shows images 
of lobules, which are not recognizable in the HRME image, but can be identified in the SI-
HRME and confocal images based on relatively small nuclear size and distinct acini [1]. The 
third row of Figure 8-1 shows images of DCIS. While there is too much out-of-focus light to 
recognize DCIS in the HRME image, the SI-HRME and confocal images of DCIS show enlarged 
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nuclei within a circular area, which are indicative of in situ carcinoma. The fourth row of Figure 
8-1 shows images of IDC. As in the images of DCIS, there is too much out of focus light in the 
HRME image to recognize IDC, while the SI-HRME and confocal images show enlarged nuclei 
arranged in disorganized clusters, suggestive of invasive carcinoma [1]. In the SI-HRME images 
of lobules, DCIS, and IDC there is a visually apparent reduction in background light relative to 
HRME images, which makes these features visually comparable to the corresponding confocal 
and histologic images. Incorporating structured illumination improves visual assessment of sites 
with dense nuclei, such as lobules, DCIS, and IDC.  
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Figure 8-1: Non-neoplastic and neoplastic features imaged with HRME, structured illumination HRME, confocal 
fluorescence microscopy, and histology with H&E staining. Non-neoplastic features shown are blood vessels (top row) and 
lobules (second row). Neoplastic features shown are cribriform pattern DCIS (third row) and invasive ductal carcinoma 
(fourth row). Scale bar is 100 µm for all images.  
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Figure 8-2: Representative HRME and SI-HRME images of a neoplastic site (right) and a non-neoplastic site (left) in 
human breast tissue specimens stained with Lugol’s Iodine. A,B: Breast tissue stained with proflavine and imaged with 
HRME.  C,D: Breast tissue stained with proflavine and imaged with SI-HRME. E,F: Breast tissue stained with Lugol’s 
Iodine and imaged with HRME. G,H: Breast tissue stained with Lugol’s Iodine and imaged with SI-HRME. Scale bar is 
100 µm for all images. 
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Figure 8-2 shows representative HRME and SI-HRME images of neoplastic and non-
neoplastic sites stained with Lugol’s Iodine. The left column of Figure 8-2 shows HRME and SI-
HRME images of benign tissue, which is recognizable in both HRME and SI-HRME images 
based on the presence of sparse nuclei with distribution and size expected in normal breast 
stroma [15]. The right column of Figure 8-2 shows HRME and SI-HRME images of neoplasia, 
which is identified based on the presence of large nuclei with crowded and disordered 
arrangement [15]. Application of Lugol’s Iodine reduces background fluorescence in SI-HRME 
and HRME images.  
Figure 8-3 shows contrast measured in confocal images of tissue stained with proflavine 
and HRME and SI-HRME images of tissue stained with proflavine or Lugol’s Iodine and 
proflavine. Mean contrast is highest in confocal images stained with proflavine. However, mean 
contrast was not significantly different between confocal and SI-HRME images of tissue stained 
with proflavine. Incorporating structured illumination significantly increased contrast in HRME 
images of tissue stained with proflavine (p < 0.001). Topical application of Lugol’s Iodine 
significantly increased mean image contrast in HRME images (p < 0.01), but not in SI-HRME 
images. There was no significant difference in contrast between HRME and SI-HRME images of 
tissue stained with Lugol’s Iodine or between SI-HRME images of tissue stained with proflavine 
or Lugol’s Iodine. 
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Figure 8-3: Gray level co-occurrence matrix-based contrast measured in confocal, HRME, and SI-HRME images of tissue 
stained with proflavine or Lugol’s Iodine (contrast agent indicated in parentheses). “n” indicates the number of sites 
represented by each box and whiskers. Statistically significant differences in mean contrast are indicated by asterisks (*); 
p < 0.05 (*), p < 0.001 (***). 
 
8.4 Discussion 
 
The objective of this study was to determine if image acquisition with structured 
illumination and topical application of Lugol’s Iodine improve contrast in HRME images of 
breast tissue. Quantitative evaluation of mean image contrast showed that structured illumination 
produced images with comparable contrast to confocal images and increased mean contrast in 
HRME images of tissue stained with proflavine (Figure 8-3). Although visual assessment 
indicated that Lugol’s Iodine application could potentially reduce background fluorescence in 
HRME and SI-HRME images of neoplasia (Figure 8-2), mean contrast was not significantly 
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higher in HRME and SI-HRME images of tissue stained with Lugol’s Iodine compared to 
proflavine (Figure 8-3).  
There are a few limitations associated with this study. The data were acquired at a single 
center and visual assessment was performed by one reader. Future studies with multiple readers 
are needed to verify if neoplasia can be identified in HRME and SI-HRME images of specimens 
from a larger group of patients. 
In conclusion, the findings of this study suggest that structured illumination can be used 
to increase contrast in HRME images of breast and that SI-HRME could potentially be used to 
rapidly characterize fresh breast tissue. SI-HRME may have the potential to address the 
limitations of current techniques for intraoperative tumor margins assessment. However, a future 
study is needed to evaluate the feasibility of using SI-HRME to identify neoplasia.   
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9 CHAPTER 9: Conclusion 
9.1  Summary and Research Contributions 
Breast cancer is the most common form of cancer for women worldwide [6]. Several 
studies have shown that outcomes are better for women whose disease is detected at an early 
stage [5, 6, 12]. However, current imaging tools provide limited ability to rapidly diagnose early 
lesions. There is a crucial need for research to improve rapid lesion diagnosis and assessment of 
excised tumor margins and sites of surgical resection.  
The standard for diagnosis of breast cancer lesions is histologic assessment, which also 
typically requires immunohistochemistry (IHC) to assess relevant biomarkers. However, both 
histologic assessment and IHC require extensive preparation and staining and may need to be 
repeated in cases where lesions are missed due to sampling error [114, 135, 136]. In addition, the 
standard criteria that are currently used for breast lesion diagnosis are vague and subjective, and 
there is an unacceptable degree of inter- and intra-observer variability in diagnosis of lesions [81, 
83, 86, 221, 222].  
Optical imaging has the potential to address the limitations of traditional methods to 
diagnose breast cancer. Optical imaging systems can provide the ability to image tissue in real 
time with minimal tissue preparation. Several optical approaches have been used to quickly 
characterize suspicious breast lesions [90-94, 96, 99, 101, 120, 121, 223, 224]. With the 
introduction of fiber optic probes, images can be acquired intraoperatively with high spatial 
resolution to visualize cellular morphology and tumor microenvironment [99-101]. A number of 
high resolution imaging approaches have been proposed to characterize breast lesions, including 
optical coherence tomography (OCT), second harmonic generation (SHG) imaging, confocal 
reflectance and fluorescence microscopy, and high resolution microendoscopy (HRME).  The 
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need for rapid breast lesion diagnosis and tumor margin assessment has motivated investigation 
of imaging techniques with the potential to inspect tissue in real time, to improve selection of 
tissue to remove for diagnosis, and to image a greater tissue volume than can be biopsied. There 
is also a need for quantitative criteria that can be used to objectively evaluate tissue and limit 
inter- and intra-observer variability in breast lesion diagnosis.  
As described in Chapter 3, I performed a study to investigate if confocal fluorescence 
microscopy, with its proven ability to image intact tissue with diffraction limited spatial 
resolution [96, 120, 121, 225-227], could yield images with sufficient resolution/quality to 
enable identification of early neoplasia in the breast. Following topical application of proflavine, 
a vital fluorescent dye targeting cell nuclei [99, 100, 122], I acquired images of surgically 
resected breast tissue and core needle biopsy specimens. The images from this study were 
compiled into a library, which were used to compare the ability of pathologists to visually assess 
normal, benign, and early neoplastic breast tissue in images acquired using confocal fluorescence 
microscopy and traditional histopathology. Neoplasia was identified with over 90% sensitivity 
and specificity in both confocal and histologic images. To further characterize the feasibility of 
using confocal fluorescence microscopy to evaluate breast tissue, I performed two studies 
comparing the results of visual assessment of confocal and histologic images. In order to 
determine if confocal fluorescence microscopy could be used to determine if the biopsy 
specimens contained adequate tissue for diagnosis and molecular testing, I performed the study 
described in Chapter 4 to estimate tumor cellularity in grayscale and pseudo-colored confocal 
images and histologic images of 23 core needle biopsy specimens. The results showed moderate 
agreement based on a kappa coefficient (κ = 0.477 ± 0.088) between assessments of tumor 
cellularity in histologic and confocal images. As described in Chapter 5, I performed a study to 
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evaluate agreement between visual assessment of diagnosis and tumor grade in confocal and 
histologic images of 30 neoplastic breast specimens. Neoplasia was correctly identified in 
confocal images of 29 of 30 specimens. 24 of 30 specimens were diagnosed as the same type of 
neoplasia and 21 of 30 specimens were assigned the same grade in confocal and histologic 
images. The results of these studies demonstrate that images acquired with confocal fluorescence 
microscopy contain sufficient detail to evaluate neoplastic breast tissue. However, the findings 
described in Chapter 5 suggest that confocal images are limited in classification of tumor type 
and grade. This limitation could potentially be addressed by developing fluorescent dyes to 
identify features that can cause misclassification in confocal images, such as inflammation [228] 
and necrosis [229].  
In order to address the need for quantitative criteria to evaluate breast tissue, I completed 
two studies to develop and evaluate computerized algorithms for quantitative analysis of breast 
architecture. I collaborated with researchers at Duke University to develop computerized 
algorithms to segment and quantitatively evaluate breast cell nuclei and breast ducts. These 
parameters were used to assemble a decision tree model that classifies images of breast tissue as 
benign or malignant with an overall accuracy of 90%. To address the second specific aim of this 
research, I developed a computerized algorithm to segment and measure confocal fluorescence 
images of adipocytes adjacent to and far from the margins of neoplastic breast lesions and in 
non-neoplastic tissue, as described in Chapter 7.  The results of this study indicate that 
adipocytes have significantly different phenotypic parameters adjacent to neoplastic lesions 
versus in non-neoplastic stroma and provide quantitative support for previous studies with 
similar findings [49, 50, 53, 230]. The findings from the research described in Chapters 6 and 7 
indicate that confocal images can be used to rapidly acquire high resolution images of fresh 
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breast tissue and that quantitative criteria can be used to continue development of objective 
criteria to evaluate breast neoplasia and the surrounding microenvironment.  
The third specific aim of this research was to evaluate a high resolution microendoscope 
(HRME) system for characterization of breast morphology.  Fiber optic tools, including confocal 
microscopy and HRME, have been developed for high resolution imaging of tissues in situ [101, 
105, 106, 190].  While HRME offers the advantages of simplicity and low cost, it does not 
provide sufficient rejection of out-of-focus light to enable successful imaging of breast tissue. As 
described in Chapter 9, I explored tissue preparation and image acquisition techniques to 
improve background light rejection, including topical application of Lugol’s Iodine [211, 212, 
216, 217, 219] and an HRME system with the option to use structured illumination (SI-HRME) 
[105, 106, 231]. Breast tissue samples were imaged using HRME and SI-HRME and stained 
with proflavine and Lugol’s Iodine. Confocal fluorescence microscopy was used to acquire 
images of the same specimens to guide image acquisition and as a reference for image contrast. I 
analyzed images obtained during this study using qualitative criteria of breast architectural 
features and quantitative metrics of image contrast. The results demonstrated that structured 
illumination produces images with comparable contrast to confocal images and significantly 
higher contrast than HRME images acquired with standard illumination. While mean image 
contrast was elevated in HRME and SI-HRME images of neoplastic tissue compared to non-
neoplastic tissue stained with Lugol’s Iodine, further study is needed to evaluate the potential of 
Lugol’s Iodine to improve contrast in images of breast tissue.  
9.2  Future Research Directions 
 
If the high resolution optical imaging techniques developed and validated with this 
research prove adequate for evaluation of breast tissue specimens in large, multicenter studies, 
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these techniques could be useful in a number of clinical scenarios.  Initially, high resolution 
optical imaging could be used to immediately evaluate the adequacy of tissue in core biopsy 
specimens and then to provide real time diagnostic results. Objective, quantitative criteria for 
evaluation of breast tissue could potentially be used to assist pathologists in rapid classification 
of neoplastic and non-neoplastic tissue, including for determining if excised tissue specimens 
have positive or negative margins. Finally, because images can be obtained in real time without 
the need for extensive processing, high resolution imaging may be useful to provide histologic 
diagnosis in low-resource settings where infrastructure for traditional histologic preparation is 
not available [130]. 
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